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Abstract 
Background: By facilitating access to prevention and care services, HIV 
serostatus disclosure has been associated with improved physical health, psychological 
well-being, and improved health behaviors for people living with HIV/AIDS (PLWHA). 
Disclosure to sexual partners, in particular, can help prevent the forward transmission of 
HIV.  Disclosure can increase social support but can also lead to negative social 
outcomes including stigma and discrimination. Thus, disclosing HIV status to friends, 
family, and sexual partners is a complex psychosocial challenge that PLWHA face, 
particularly adolescents and youth who have an increased lifespan due to current effective 
treatment protocols.  
Objectives: This study had three objectives: 1) to determine gender-related 
differences in the rate and patterns of HIV serostatus disclosure to family, friends and 
sexual partners among HIV-positive youth in Haiti; 2) to identify gender-specific 
relational and psychosocial predictors of HIV disclosure to sexual partner; and 3) to 
qualitatively explore and describe motivations and experiences related to HIV disclosure 
in this population.  
Methods: A cross-sectional study was conducted in a random sample of 680 
sexually active HIV-positive young adults (18-29 years) from six clinics in Port-au-
Prince, Haiti. Socio-demographic, health, sexual and reproductive history, sexual 
behavior, psychosocial and disclosure data were collected using a pre-tested interviewer-
administered structured questionnaire. Rates and patterns of HIV serostatus were 
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described, and factors associated with disclosure to all sexual partners in the past 3 
months were analyzed using hierarchical logistic regression models, separately by 
gender. Qualitative data was collected through individual in-depth interviews with a 
purposefully selected sample of 12 young adult participants to explore whom they chose 
to disclose to, how they disclosed to these individuals, and how these individuals reacted. 
Content analysis allowed for the description of motivations and experiences related to 
HIV disclosure in this population.  
Results: Slightly over half (56%) of participants had told at least one person 
about their HIV status. Female respondents were more likely than male respondents to 
have disclosed to family or friends. Male youth were more likely to disclose their status 
for the first time to sexual partners (35%), while female youth were more likely to choose 
their mother as their first confidant (51%). Overall, 33% of participants reported having 
disclosed their HIV status to all their sexual partners from the last 3 months, with no 
significant difference across genders. For both genders, older age and being unaware of 
partners' HIV status were significantly associated with lower odds of HIV serostatus 
disclosure. Additionally for young males, disclosure stigma was negatively associated 
with disclosure while HIV acceptance and personalized stigma were significant 
predictors of disclosure. Female youth who were single, had casual or multiple partners, 
and experienced greater personalized stigma were less likely to disclose, whereas the 
availability of social support was positively associated with disclosure to all sexual 
partners. While disclosure to sexual partners was motivated primarily by a desire to 
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encourage partners to test for HIV and increase condom use, or by a sense of moral 
responsibility, important contextual differences emerged in qualitative analysis with 
regards to barriers to disclosure, particularly fear of stigma and fear of partner’s reaction. 
Conclusion: Rates of HIV serostatus disclosure to family, friends and sexual 
partners were low among this population of HIV-positive youth in Port-au-Prince. 
Context-specific gender-sensitive interventions are needed to increase social support, 
reduce HIV-related stigma, and assist youth living with HIV in making effective 
decisions on disclosure that will ultimately improve their well-being and quality of life. 
Further research is necessary to better understand the process and outcomes of HIV 
serostatus disclosure to sexual partners, as well as the relationship between HIV 
serostatus disclosure and sexual risk behaviors in this young HIV-positive population. 
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1. Background  
1.1 Overview of HIV Serostatus Disclosure 
As the fight against HIV/AIDS enters its third decade, the emphasis worldwide is 
on adopting and scaling up the most effective strategies in order to prevent new infections 
and improve the quality of life of those who are already infected (Eustace & Ilagan, 
2010). HIV testing and counseling is recognized as a critical prevention and treatment 
tool in the control of the HIV epidemic (Maman & Medley, 2004). With the advent of 
antiretroviral therapy (ART) and effective treatment protocols that have drastically 
prolonged survival, HIV is now perceived as a manageable chronic condition instead of a 
terminal illness (Holstad, Foster, Diiorio, McCarty, & Teplinskiy, 2010; Osinde, Kakaire, 
& Kaye, 2012). Therefore, it is important to ensure the physical, mental and sexual health 
of the growing number of people living with HIV/AIDS (PLWHA) (Golub, Tomassilli, & 
Parsons, 2009). HIV serostatus disclosure is the first step to implementing a range of 
prevention and care behaviors, which ultimately will improve overall well-being and 
quality of life for PLWHA and prevent the forward transmission of HIV. 
    
1.2 HIV Disclosure: an Important Public Health Goal 
Disclosure is defined as the autonomous revelation of one’s status to another 
individual or group of individuals (Adejumo, 2011). Considered one of the most complex 
psychosocial challenges and an emotionally stressful event facing people living with 
HIV/AIDS, it is also viewed as an opportunity to “open up” the HIV epidemic in the 
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hopes of ending stigma and discrimination against HIV-positive individuals (Chaudoir, 
Fisher, & Simoni, 2011; Obermeyer, Baijal, & Pegurri, 2011; UNAIDS, 2000).  
HIV disclosure has significant implications for public health outcomes (Chaudoir 
et al., 2011; World Health Organization, 2003). HIV serostatus disclosure to sexual 
partners supports risk reduction behaviors that ultimately decrease transmission of HIV, 
while also facilitating access to prevention, care and treatment services (King et al., 
2008).  Management of HIV can also be improved by health behaviors, such as 
participation in prevention of mother-to-child transmission of HIV (PMTCT) programs 
(Maman & Medley, 2004). Additionally, public health benefits can be obtained, as 
disclosure to family and friends can lead to increased social support, which can facilitate 
initiation of and adherence to HIV treatment that, in turn, lower the risk of transmission 
to prospective sexual partners (Ammassari et al., 2002; Strirratt et al., 2006; Thoth, 
Tucker, Leahy, & Stewart, 2012; Wadell & Messeri, 2006).  
 
1.3 Individual-Level Benefits Versus Risks of HIV Disclosure  
 At the individual level, self-disclosure of one’s HIV status can provide numerous 
benefits to PLWHA. HIV disclosure can lead to increased availability of social support 
(Hays et al., 1993; Medley, Garcia-Moreno, McGill, & Maman, 2004), reduced anxiety 
and depression, and beneficial effects on the individual’s physical health and overall 
well-being (Collins & Miller, 1994; Kalichman, DiMarco, Austin, Luke, & DiFonzo, 
2003; Thoth et al., 2012).  
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Despite these positive benefits, disclosure may sometimes have negative conse-
quences. Potential risks of HIV serostatus disclosure include blame, abandonment and 
rejection (Pool, Nyanzi, & Whitworth, 2001), physical abuse and violence (Gielen et al., 
2000; Temmerman, Ndinya-Achola, Ambani, & Piot, 1995), disgrace to self and family 
(Chandra, Deepthivarma, & Manjula, 2003), stigma and discrimination (Kilewo et al., 
2001), accusations of infidelity, and loss of economic support (Medley et al., 2004). A 
person living with HIV/AIDS faces the complex decision of whether or not to disclose. 
The balance of potential risks and benefits of secrecy compared to disclosure is a 
fundamental step in coping with the disease (Bouillon et al., 2007; Medley, Kennedy, 
Lunyolo, & Sweat, 2009) and often leads to selective disclosure by PLWHA based on the 
importance of the relationships and the level of trust with the different types of confidants 
(Obermeyer et al., 2011). 
 
1.4 Theoretical Frameworks for Understanding HIV Disclosure 
HIV disclosure can be seen as a complex, multidimensional process of making a 
decision about whom to inform about one’s serostatus, and why, when, where and how to 
disclose (Eustace & Ilagan, 2010). Several descriptive frameworks have been proposed to 
identify factors affecting disclosure likelihood. According to the disease progression 
theory (Serovich, 2001), PLWHA are likely to disclose only as their illness advances and 
the secret about their HIV diagnosis can no longer be kept. This theory, which has been 
supported by studies conducted during the pre-ART era revealing an association between 
worsening health and increased likelihood of disclosure (Hays et al., 1993), may be less 
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applicable in light of the current widespread availability and effectiveness of ART 
(Przybyla, 2009). The competing consequence theory (Serovich, 2001) has also found 
support in the growing literature on disclosure.  It posits that PLWHA are more likely to 
disclose if the perception of expected benefits outweighs the potential risks (Emlet, 
2006).  
Building on previous theories, while expanding on the decision-making process 
for disclosure, Kimberly and Serovich (1995) proposed a framework that outlines the 
disclosure process in six steps: 1) adjustment to the diagnosis; 2) evaluation of personal 
disclosure skills; 3) evaluation of the appropriateness of disclosure; 4) assessment of the 
circumstances for disclosure; 5) anticipation of potential reactions of disclosure 
recipients, and 6) identification of the motivations for disclosure. Bairan and colleagues 
(2007) proposed a model based on types of social relationships to explain HIV disclosure. 
According to this model, social relationships are categorized as sexual and nonsexual, 
with different disclosure levels and patterns based on the nature of the relationship with 
the confidant (Bairan et al., 2007).  
More recently, the Disclosure Processes Model (DPM) has been proposed to 
conceptualize disclosure as a single process within a continuous series of lifetime events 
that involves decision-making and outcome processes (Chaudoir & Fisher, 2010). The 
DPM highlights the impact on each disclosure event of: antecedent goals (approach or 
avoidance goals) affecting the likelihood of discrete disclosure events, the disclosure 
event itself, mediating processes such as social support, outcomes at the individual, 
dyadic or contextual levels, and a feedback loop (Chaudoir et al., 2011). As such, this 
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model provides a comprehensive framework for studying when and why interpersonal 
and verbal disclosure will be favorable for HIV-positive individuals, while putting special 
emphasis on connections between all aspects of the disclosure process (Chaudoir & 
Fisher, 2010).  
 
1.5 HIV Disclosure Rates and Practices 
There is considerable variation across settings in the rates of HIV serostatus 
disclosure. In developed countries, disclosure rates are high compared to developing 
countries. A review of the HIV disclosure literature reports that the average rate of 
disclosure to current and/or steady sexual partners was 79% (range 42 - 100%) in 
developed countries. Conversely, in the developing world, particularly in Africa, the 
average rate of HIV disclosure was 49% (range 16 - 86%) (World Health Organization, 
2003). Several studies from the developing world have shown that 10% to 78% of 
women do not disclose their HIV test results to anyone, compared to only 3% to 10% in 
developed countries (Maman & Medley, 2004).These differences can be attributed to 
high levels of stigma and discrimination in certain settings as well as differential access 
to health and support services (Obermeyer et al., 2011).  
 The rates and patterns of HIV disclosure vary greatly within settings, by ethnicity 
and gender, with the lowest rates reported in studies among women attending antenatal 
care (World Health Organization, 2003).  A study conducted in Tanzania found that HIV-
positive individuals were most likely to share their HIV test results with their parents 
(49%), followed by their spouses (25%) and then their sexual partners (19%) (MacNeil, 
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Mberesero, & Kilonzo, 1999).  In contrast, also in Tanzania, lower disclosure rates to 
family (5.6%) compared to partners (16.7 %) were found in a study among women 
enrolled in an HIV perinatal transmission trial (Kilewo, et al., 2001). One study 
conducted in the United States found that the highest rates of disclosure were reported to 
mothers among a sample of African-American women (Armistead, Morse E., Forehand, 
Morse P., & Clark, 1999), while other studies have reported higher rates of disclosure to 
non-family members (Simoni et al., 1995).  
 Disclosure is not a one-time event but rather a process that occurs over 
time (Chaudoir & Fisher, 2010; Obermeyer et al., 2011). Skogmar and colleagues (2006) 
found that nearly all (92%) respondents in a South Africa-based study disclosed to at 
least one person in their social network, with 15% waiting over a year to tell their 
partners. In Tanzania, it was found that only 22% of pregnant women had disclosed to a 
partner in the 2 months after their diagnosis while 40% had done so after 4 years 
(Antelman et al., 2001). Among a sample of gay Latino men in the United States, half 
had disclosed to someone on the day of their diagnosis, and another 15% disclosed within 
a few days, however about 20% did not tell anyone for a year or more (Zea, Reisen, 
Poppen, Bianchi, & Echeverry, 2005). Other studies have found that disclosure of HIV 
status had a positive association with the length of time since diagnosis (D'Angelo et al., 
2001; Niccolai, King, D'Entremont, & Pritchett, 2006), and with disease progression 
(O'Brien et al., 2003). 
Qualitative studies have also been used to explore differences among disclosers 
and non-disclosers, looking specifically at the process of communication during 
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disclosure as well as coping styles after disclosure (Obermeyer et al., 2011). Selective 
disclosure has been identified as one of the most frequent strategies used by PLWHA, as 
the decision to whom to disclose was often based of particular criteria related to the 
nature and quality of the relationship with the confidant (Hult, Wrubel, Branstrom, Acree, 
& Moskowitz, 2012; Sowell, Seals, Phillips, & Julious, 2003). 
 
1.6 Factors Motivating or Hindering HIV Disclosure 
People living with HIV/AIDS face the constant struggle of deciding whether or 
not to disclose, when and to whom. Factors motivating or hindering disclosure have been 
extensively studied in numerous settings and were found to be similar, especially in 
developing countries. Several studies have concluded that a sense of personal moral 
responsibility or the desire to have a partner tested for HIV was the major reason cited for 
disclosure to sexual partners, whereas the need for social support motivated disclosure to 
family and friends (Simoni, et al., 1995; Hult et al., 2012). Conversely, the most common 
barriers to disclosure included fear of blame and abandonment, fear of rejection (Pool et 
al., 2001), fear of violence (Temmerman et al., 1995), fear of upsetting family members 
and causing disgrace to self and family (Chandra et al. 2003), fear of accusations of 
infidelity, and fear of losing economic support (Medley et al., 2004; Sowell et al., 2003; 
Maman et al., 2003). 
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1.7 Legal and Policy Context of HIV Disclosure 
Low rates of HIV disclosure to sexual partners raise questions about the ethics of 
balancing medical confidentiality and well-being of PLWHA with the rights of sexual 
partners (Bott & Obermeyer, 2013). In developed countries, like in Canada and in several 
states of the United States of America, PLWHA are required by law to disclose their HIV 
status to their current and prospective sexual partners (Galletly, Glasman, Pinkerton, & di 
Franceisco, 2012). Similarly, in a number of developing countries, including Benin, 
Burkina Faso and Cape Verde, legislation has been passed into law criminalizing HIV 
transmission by HIV-positive individuals, mandating disclosure to partners and 
authorizing involuntary disclosure by health workers (Bott & Obermeyer, 2013). These 
laws and policies have sparked intense debates in the legal and public health realms (Bott 
& Obermeyer, 2013; UNAIDS, 2008).   
 
1.8 Influence of Socio-Economic Factors and Gender on HIV 
Disclosure 
Disclosure rates vary according to the availability of institutional sources of 
support, especially in the urban areas (Norman, Chopra, & Kadiyala, 2007; Obermeyer et 
al., 2011). Level of education has also been linked to levels of disclosure. Akani and 
Erhabor (2006) found that Nigerian respondents with higher educational attainment were 
more likely to disclose compared to their less-educated counterparts. Gender plays an 
important role in the association of HIV disclosure to economic factors. A study 
conducted in Kenya found that women with limited resources were more likely to 
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disclose to their partners in order to secure continued economic support (Farquhar, et al., 
2001). The evidence linking gender to disclosure has been mixed. Studies from Kenya 
and South Africa found higher rates of HIV disclosure by women (Katz et al., 2009; 
Olley, Seedat, & Stein, 2004), whereas other studies had found no significant differences 
like in Ethiopia (Deribe, Woldemichael, Bernard, & Yakob, 2009). However, there are 
substantial differences across genders regarding the reasons for nondisclosure including 
fear of physical violence or rejection among women and concern about infecting the 
partner among males (Deribe et al., 2009).    
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2. Introduction 
 
2.1 HIV/AIDS Among Young Adults 
The HIV/AIDS pandemic continues to be a major concern worldwide, with young 
people bearing a disproportionate HIV burden. In 2009, globally there were 2.6 million 
people who became newly infected with HIV, of whom approximately 40% were 
between the ages of 15-24 (UNAIDS, 2012). Young people are considered to be at the 
center of the HIV/AIDS epidemic (Monascha & Mahyb, 2006). They are especially 
vulnerable to HIV because of unsafe sex, substance use, and the lack of access to HIV 
information and prevention services (UNAIDS, 2012). Early sexual activity, unplanned 
and coerced sexual relations, sexual abuse and exploitation increase the vulnerability of 
youth. Moreover, there are biological, social and economic factors that render young 
women especially vulnerable to HIV (UNAIDS, 2010). 
 
2.2 HIV/AIDS in Haiti 
Haiti has been impacted by HIV/AIDS more severely than any other country in 
the Caribbean, with prevalence rates reaching nearly 5% in the 1990s (Gaillard, et al., 
2006). Despite a spectacular decline in HIV prevalence among the general population, 
Haiti continues to bear the largest burden of HIV in the region with a national prevalence 
of 2.2% among individuals 15 to 49 years old (1.7% for men and 2.7% for women) (Haiti 
Demographic and Health Survey DHS, 2012). Primary factors associated with the HIV 
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epidemic in Haiti include poverty, socio-political instability, limited access to healthcare, 
HIV-related stigma, and social norms promoting multiple sexual partnerships 
(Hempstone, Diop-Sidibe, Ahanda, Lauredent, & Heerey, 2004). The number of PLWHA 
in Haiti is growing. Estimated at 120,000 in 2008 (UNAIDS, 2010), it is now estimated 
that there were close to 150,000 at the end of 2013, with approximately 40,000 PLWHA 
in the 15 to 29 age range alone (Ministère de la Santé et de la Population MSPP, 2013a.). 
Characterized as a generalized epidemic in Haiti, HIV is transmitted primarily 
through sexual contact. Among the groups considered most-at-risk for HIV are young 
people, commercial sex workers (CSW) and men who have sex with men (MSM), with 
considerable overlap between the categories (MSPP, 2013b.). According to the Haiti 
Demographic and Health Survey 2012, female youth (15-24 years) have a higher 
prevalence than male youth, with the greatest gender disparity between ages 20 and 24. 
Overall, HIV prevalence stands at 1.3% for female youth compared to 0.9% for male 
youth (age range: 15-24).  Poverty is believed to foster risk behaviors among young 
people who are unemployed and who may exchange sex for support (Fitzgerald, Behets, 
& Caliendo, 2000; Farmer, 2004). A recent seroprevalence study conducted by the 
Haitian Ministry of Health and Population Services International (PSI) using respondent-
driven sampling among female commercial sex workers and men who have sex with men 
found HIV prevalence rates of 8.4% and 18.1% for CSW and MSM, respectively (MSPP, 
2013b).  
With the advent of antiretroviral therapy (ART), more people with HIV are living 
longer. Consequently, the continued spread of HIV may result from those who know their 
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HIV-positive status but nonetheless engage in high-risk sexual behaviors including 
unprotected sex and multiple concurrent partnerships (Crepaz & Marks, 2002; McGowan 
et al., 2004). It is also important to note that there are no laws criminalizing the 
transmission of HIV in Haiti (UNAIDS, 2013).  
 
2.3 HIV Disclosure Research Among Youth and Young Adults  
With an increased lifespan due to HIV treatment, HIV-positive youth and young 
adults are particular in that they will most likely be engaging in sexual activity for longer 
periods of time as compared to adults. HIV disclosure to family, friends and sexual 
partners is thought to play an important role in HIV prevention, as it can have positive 
outcomes related to social support and increased quality of life. The budding literature on 
HIV-positive youth disclosure, resulting from studies conducted for the most part in the 
United States and Canada, reports a wide range of rates of self-disclosure. In a study of 
disclosure of HIV status among HIV-infected youth, it was found that 87% of youth had 
disclosed to at least one family member and that 63% of female youth with  no more than 
three partners had disclosed to all their partners compared to only 9% of females with 
more than 4 partners (Lee, Rotheram-Borus, & O’Hara, 1999). Other more recent studies 
have reported rates from 50% (Petersen et al., 2010) to 89% (Rongkavilit et al., 2010). 
Youth vary in whom they chose to disclose to, especially with regards to their mode of 
infection. Indeed, behaviorally-infected youth have faced challenges in disclosing to their 
parents, whereas concerns about revealing their mother’s status have impeded disclosure 
in perinatally-infected youth (Michaud et al., 2009). Batterman, Rice and Rotheram-
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Borus (2005) found that youth who had been diagnosed for a greater length of time were 
more likely to disclose to at least one person compared to youth who were recently 
diagnosed, a finding that was similar to that found in the adult literature. Seventy-seven 
percent of youth (under 25 years) had disclosed to their mothers, while 47% disclosed to 
their fathers in a study by D'Angelo and colleagues (2001). In this same study, youth of 
both genders were found to have disclosed their HIV infection preferably to their 
mothers. Other studies have found marked gender differences however, with young 
women being more likely to disclose to their families and young men being more likely 
to inform their friends (Rongkavilit et al., 2010). Moreover, sexual orientation has been 
associated with disclosure patterns as young HIV-positive MSM were less likely to 
disclose their serostatus to their families because it would raise questions about their 
sexuality (Rongkavilit et al., 2010). Social support to HIV-positive youth has been 
instrumental in reducing stigma and isolation. A positive association exists between 
disclosure and social support (Wiener & Battles, 2006). Disclosure and social support 
most likely interact in a cycle, with one predicting the other. 
There is tremendous inconsistency in the literature where disclosure of HIV-
positive youth to sexual partners is concerned. Various rates of disclosure to sexual 
partners have been reported in different settings, from 30% (Birungi et al., 2009) to more 
than 60% (Michaud et al., 2009). Other studies have looked at serosorting behavior 
among PLWHA, as a measure of increased positive mental health outcomes (Golub et al., 
2009). The unpredictability in rates of disclosure is best understood when HIV status and 
relationship type of the partner is considered. Several studies have shown that disclosure 
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is more likely when the partner is HIV-positive and considered a main partner (D’Angelo 
et al., 2001; O’Brien et al., 2003). HIV-positive youth who have disclosed to their family 
and felt supported were more likely to disclose to their sexual partners (Parsons, Butler, 
Kocik, Norman, & Nuss, 1998; Wiener & Battles, 2006). More recently, in a study 
conducted in the United States with youth (16-24 years), researchers found that 40% of 
participants had had a sexual relationship with a partner without disclosing their HIV 
status to that partner (Dempsey, MacDonell, Naar-King, Lau, & Adolescent Medicine 
Trials Network for HIV AIDS interventions,  2012). Other findings included that 
disclosure was more frequent when the HIV status of the sexual partner or confidant was 
known and was less frequent when participants reported multiple sexual partners 
(D'Angelo et al., 2001). 
HIV-positive youth have identified concerns related to both fear of the actual 
disclosure event and fear of the consequence of disclosure (Hosek, Harper, & Domanico, 
2000). The fear of unauthorized disclosures subsequent to the initial self-disclosure was 
also a major cause of anxiety for HIV-positive youth (Leonard, Markham, Bui, Shegog, 
& Paul, 2010). The main barriers to disclosure reported in the literature include stigma, 
fear of rejection, lack of confidence, bad communication skills, lack of emotional 
resources (Thoth et al., 2012). 
 
2.4 HIV Disclosure Research in Haiti 
Very little research has been conducted in Haiti on HIV disclosure. A review of 
the literature revealed only two studies conducted in the Haitian context on this topic. In 
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the first study which used case studies of HIV-positive clients (Mean age = 33, SD = 8), 
women did not disclose their serostatus to their sexual partners because of the fear of 
violence, abandonment and loss of financial support (Fitzgerald, Maxi, Marcelin, 
Johnson, & Pape, 2004). In a more recent study of disclosure among HIV-positive 
alcohol users, Conserve, King, Devieux, Jean-Gilles, and Malow (2014) found that the 
disclosure rate to sexual partners was relatively low (38.6%) in a sample of 258 HIV-
positive individuals (age range: 17-56). They also found that having an HIV-negative or 
HIV-unknown partner and having more than one sexual partner were associated with 
decreased odds of disclosure. 
Prevention programs targeting young PLWHA are critical in reducing the spread 
of the virus. Positive prevention efforts target PLWHA to promote risk reduction 
behaviors including condom use as well as HIV serostatus disclosure. A major challenge 
to positive prevention interventions is the social context of high levels of stigma and 
discrimination, which makes the disclosure process very difficult. No studies have yet 
sought to understand HIV disclosure among the HIV-positive young adult population 
(under 30 years) in Haiti. A better understanding of the disclosure process and 
mechanism is needed in order to enhance positive prevention interventions targeting 
young people in Haiti. 
 
2.5 Study Objectives 
Given the high burden of HIV and the increasing number of HIV-positive youth 
in Haiti, a better understanding of the mechanisms through which young PLWHA 
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disclose their serostatus is crucial to inform programs targeting this population. Using the 
Disclosure Processes Model (Chaudoir & Fisher, 2010) as a theoretical backdrop, this 
study intends to add to the limited knowledge available in this area of interest in the 
Haitian setting and identify potential actions for secondary HIV prevention programming. 
The study’s main objectives are: 1) to determine gender-related differences in the rate 
and patterns of HIV serostatus disclosure to family, friends and sexual partners among 
HIV-positive young adults in Haiti; 2) to identify gender-specific relational and 
psychosocial predictors of HIV disclosure to sexual partners; and 3) to qualitatively 
explore and describe motivations and experiences related to HIV disclosure in this 
population.  
 
2.6 Research Questions, Hypotheses, and Conceptual Model 
 
2.6.1 Research Questions and Hypotheses 
In order to address the proposed study’s analytical objectives, three main research 
questions and their associated hypotheses are proposed. 
 
Research Question 1: What are the rate and patterns of HIV serostatus disclosure to 
family, friends, and sexual partners among HIV-positive young adults in Haiti? Do they 
vary by gender? 
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Hypothesis 1.1: HIV-positive young adults are more likely to disclose to their family 
compared to their friends and sexual partners. 
Hypothesis 1.2: HIV-positive young adults are more likely to disclose to their family 
members first compared to their friends and sexual partners. 
 
Research Question 2: What are the relational and psychosocial predictors of HIV 
serostatus disclosure to sexual partners among HIV-positive young adults in Haiti? Do 
they vary by gender? 
Hypothesis 2.1: HIV-positive young adults are more likely to disclose their HIV status to 
main partners than causal partners. 
Hypothesis 2.2: HIV-positive young adults are more likely to disclose their HIV status to 
other known HIV-positive partners than to HIV-negative or unknown status partners. 
Hypothesis 2.3: HIV-positive young adults are more likely to disclose their HIV-status to 
their sexual partner if they previously disclosed to family members. 
 
Research Question 3: To what extent do HIV Acceptance, Social Support, Stigma, 
Depression, and Subjective norms predict HIV serostatus disclosure among HIV-positive 
young adults? Do they vary by gender? 
 
2.6.2 Study Conceptual Model 
The conceptual model (Figure 1) was informed by the theoretical perspective of 
the Disclosure Processes Model (Chaudoir & Fisher, 2010) and empirical findings on 
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HIV disclosure in youth subpopulations of PLWHA. This model illustrates the relation-
ship between predictor variables and HIV serostatus disclosure to sexual partners, the 
main outcome of interest for the proposed study which will focus primarily on the 
decision-making process involved in HIV disclosure. 
 
 
Figure 1: Study conceptual model 
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3. Methods 
3.1 Setting 
The setting for this project was Port-au-Prince, the capital city, located in the 
West department, the largest and most populated of the ten geographical regions of Haiti 
(Haiti DHS, 2012). In 2011, there were approximately 77,431 people living with 
HIV/AIDS (PLWHA) in this department alone, representing over half of all HIV infected 
individuals in the country (MSPP, 2013a.). This study was conducted at six sites 
randomly selected out of 17 possible sites located in the West department. All clinics are 
part of a nationwide network of clinics run by a local non-governmental organization 
(NGO) - one of the key partners of the Haitian Ministry of Health - providing a wide 
range of services including diagnosis and treatment of sexually transmitted infections 
(STI), family planning, HIV prevention services to youth and other most-at-risk 
populations (MARPs), including young commercial sex workers (CSW), men who have 
sex with men (MSM) and PLWHA. (FOSREF, 2013). The selected clinics and their 
respective catchment areas represent diverse and densely populated urban areas around 
Port-au-Prince, which have seen an influx of displaced populations in camps after the 
January 2010 earthquake.  
 
3.2 Study Population 
To be eligible for participation, individuals had to: (a) be HIV-positive, (b) be 
between 18 and 29 years old, (c) self-report at least one episode of sexual activity 
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(defined as anal or vaginal sex, with or without condom) in the past 3 months, and (d) 
have sufficient cognitive ability to provide informed consent. 
 
3.3 Study Design  
 A two-phase mixed-methods sequential explanatory design was chosen for this 
study (Creswell & Plano Clark, 2007). A cross-sectional survey was followed by 
individual in-depth interviews with a purposefully selected subsample to explain and 
contextualize results obtained during the first phase (Creswell, Klassen, Plano Clark, & 
Smith, 2011). This design was used to gain a better understanding of the complexity of 
levels and patterns of HIV serostatus disclosure among male and female HIV-positive 
Haitian young adults.  
 
3.3.1 Sampling and Recruitment  
The sample size was calculated based on the results of a previous study conducted 
in Haiti which reported a percentage of disclosure to sexual partners of 38% (Conserve et 
al., 2014), a power of 0.80, and an alpha of 0.05, in order to detect a 10% difference in 
disclosure rate between genders. A sample size of 678 (308 males and 370 females) was 
needed, considering a female-to-male ratio of 1.2:1 at the selected clinics. 
Potential participants were recruited by the clinics’ HIV counselors and support 
group moderators who identified youth who met the eligibility criteria from patient and 
support group registries. After potential participants were screened for eligibility by the 
clinics’ HIV counselors, two separate sampling frames for male and female youth were 
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created at each clinic, from which participants were selected by systematic random 
sampling with a sampling interval of 3. There were no pre-determined quotas by clinic or 
age. A total of 696 youth were selected for the cross-sectional survey, from whom a 
subset of 12 youth (5 males and 7 females) were subsequently purposefully selected to 
participate in in-depth interviews (Figure 2). Interview selection was conducted to have 
representation of age, gender, marital status and HIV disclosure experience. 
 
 
Figure 2: Sample selection process for study participants  
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3.3.2 Procedures 
The structured survey was administered by 6 trained counselors recruited from 
within the NGO’s network of clinics, based on their previous experience in counseling 
and working with youth as well as their non-affiliation to the study recruitment sites.  
Data collection training covered confidentiality issues, a review of research protocols, 
and mock interviews. Interviews were conducted in private rooms inside the clinics and 
lasted approximately 45 minutes. Participants received reimbursement for transportation 
costs as well as a telephone card worth 100 Haitian gourdes (about $2.50 US).  
Several steps were taken to increase privacy, reduce social desirability bias and 
enhance the validity of responses to sensitive questions about disclosure and sexual 
behavior for the interviewer-administered survey with this HIV-positive population. First, 
participant confidentiality was stressed throughout the study. Additionally, interviews 
were conducted in private rooms with trained youth counselors, not affiliated with the 
study sites.  
The individual in-depth interviews were administered by two local interviewers 
(one male and one female) experienced in qualitative data collection. The interviews took 
place approximately 8 weeks after the survey phase. Interviews lasted about 60 minutes 
and were conducted in private rooms at the clinic sites. All interviews were audio-
recorded with the participants’ approval. Following the in-depth interview, participants 
received reimbursement for transportation costs and a telephone card worth 100 Haitian 
gourdes (about $2.50 US). 
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3.3.3 Ethics  
Ethical clearance was obtained from both the Duke University Institutional 
Review Board and the National Haitian Bioethics Committee. Permission to conduct the 
study was obtained from the administration of the non-governmental organization 
running the six selected sites. All subjects who participated in the study had received 
post-test counseling and were aware of their HIV status. Informed consent was obtained 
from all participants prior to data collection for both the quantitative and the qualitative 
components. 
 
3.4 Measures 
3.4.1 Structured Survey  
 The quantitative instrument was developed from measures used in previous 
research conducted with HIV-positive populations, which have demonstrated validity and 
reliability in various resource-limited and cultural settings (Center for AIDS Prevention 
Studies CAPS / UCSF, 2004; Dempsey et al., 2012; Deribe et al., 2008; Finger, Clum, 
Trent, Ellen, & Adolescent Medicine Trials Network for HIV AIDS interventions, 2012; 
King et al., 2008; Osinde et al., 2012; Przybyla et al., 2013; Simbayi et al., 2007; Smith 
Fawzi et al., 2010). The measures were translated into Haitian Kreyòl and back-translated 
in English by experienced linguistic professionals. In order to judge ease of interpretation 
and response burden, preliminary drafts of the survey were pilot tested with 12 HIV-
positive youth who were not included in the study.  
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HIV disclosure to sexual partners. The primary dependent variable for this study 
was HIV serostatus disclosure to sexual partners from the past 3 months (Dempsey et al., 
2012). After having the participant list up to 5 partners with whom they had sex in the 
past 3 months, they were asked about their HIV disclosure to each using the following 
question: “Have you personally told this partner that you are HIV-positive?” The data 
was recoded categorically as disclosure to all sexual partners (full disclosure) versus 
disclosure to none or some. Participants were also asked to list the main reason why they 
disclosed their HIV status for each partner disclosed to. 
Partner relationship type. The nature of participants' relationship with their sexual 
partner(s) was assessed using the following question: " How would you describe your 
relationship with each partner: do you consider him/her as your main or casual partner?" 
The data was recorded for each reported partner and recoded into a 3-category variable: 
casual partners only, main and casual partners, and main partners only (CAPS / UCSF, 
2004).     
Partner HIV serostatus. Participants’ knowledge of their partners’ HIV status was 
assessed  using the following question: “Do you know your partner’s HIV status?" The 
data was recorded for each reported partner and recoded into a 4-category variable: HIV-
negative partners only, Unknown status only, HIV-positive only and combination of 
HIV-positive, HIV-negative, and/or Unknown (CAPS / UCSF, 2004). 
Disclosure of HIV status to others. Disclosure of HIV serostatus to others besides 
sexual partners was assessed in several ways. First, a series of sixteen structured items 
was asked to determine how many people the respondent had disclosed to since 
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diagnosis; to whom, why and when the respondent had disclosed first, second, and third, 
as well as the reaction of each confidant and how the respondent felt about subsequent 
disclosure decisions.  Additionally, open-ended items were used to determine the size of 
their friend and family networks, and how many of those friends and family members 
were aware of their diagnosis. If a respondent did not disclose to anyone, the reasons for 
non-disclosure were sought.  
Acceptance of HIV. The six-item acceptance subscale of the Illness Cognition 
Questionnaire for Chronic Diseases (Evers et al., 2001) was used to assess participants’ 
acceptance of HIV disease. Specific items included: “I have learned to live with my 
HIV", and "I think I can handle the problems related to my HIV, even if it gets worse". 
Response options ranged from 1 to 4. Items were summed, with higher scores indicating 
greater acceptance (α=0.96).  
Social support. Social support was measured using the Medical Outcomes Study 
(MOS) Social Support Survey (Sherbourne & Stewart, 1991). The twenty-item five-point 
rating scale measures four different aspects of social support: emotional/informational 
support, tangible support, affectionate support, and positive social interaction. Items were 
summed for a total social support score, with higher scores indicating more frequent 
availability of different types of support (α=0.98).  
Depression. The Center for Epidemiologic Studies Depression Scale (CES-D) 
(Radloff, 1977) was used to assess self-reported depressive symptoms. Response choices 
range from 0 to 3, indicating the frequency of depression symptoms over the previous 
week. Answers to the twenty-item scale are summed to yield an overall depression score, 
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with higher scores indicating the presence of greater depressive symptomatology 
(α=0.77). 
 Perceived HIV Stigma. To assess the extent of perceived stigma as experienced by 
respondents with regards to their HIV diagnosis, the personalized stigma and disclosure 
concerns subscales of the HIV Stigma Scale (Berger, Ferrans & Lashley, 2001) were 
used. The 18-item personalized stigma subscale, which measures the consequences of 
others knowing about one's HIV status, included items such as " I have been hurt by how 
people reacted to learning I have HIV", and  "As a rule, telling others that I have HIV has 
been a mistake". The 12-item disclosure concerns subscale, which measures issues 
related to disclosing or hiding one's HIV status from others, included items such as " I 
worry that people who know I have HIV will tell others", and "I told people close to me 
to keep my HIV a secret". Response choices on a 4-point Likert-type scale were summed 
to create a personalized stigma score (α= 0.96) and a disclosure stigma score (α=0.92), 
with higher scores indicating greater perceived stigma.  
HIV disclosure norms. Subjective norms represent a construct of the Theory of 
Planned Behavior (TPB) (Ajzen, 1991). According to the TPB, individuals are more 
likely to follow a particular health action if they believe the people whose views they 
value think they should carry out the behavior (Montano & Kapspryk, 2002). Subjective 
norms regarding HIV disclosure are thus determined by the perceived social pressure to 
disclose one's HIV status. The construct was measured with a series of items asking for 
each of three reference groups (friends, family members and sexual partners) how much 
participants agreed or disagreed with the following statement: “Most of my (friends / 
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family members / sexual partners) think that people living with HIV should always tell 
their sex partner their HIV status before having vaginal or anal sex with them.” Motiva-
tion to comply was then assessed for each reference group with the following: “In 
general, how important or unimportant is it to you what your (friends / family members / 
sexual partners) think you should do?” An overall total subjective norm score was 
obtained by multiplying scores for each normative belief by the corresponding score for 
motivation to comply and adding them together. Total scores ranged from -24 to +24, 
with positive scores indicating that the respondent experiences increasing social pressure 
to disclose. 
Sexual and reproductive history. Age at first sex and number of lifetime partners 
were recorded as continuous variables. Any living children and STI diagnosis in the last 3 
months were assessed and dichotomized into yes and no.  
Health-related characteristics. Variables characterizing the participant’s HIV 
illness included time since HIV diagnosis (categorized as: less than two years; two to four 
years; more than four years) and mode of HIV infection (categorized as: perinatally; 
sexual transmission; blood tranfusion; or I don’t know). Antiretroviral therapy (ART)  
use was determined by asking: “Are you currently taking any antiretroviral medications?” 
Socio-demographics characterisctics. Demographic variables included gender, 
age,  education, religion, employment, and marital status. The age variable was 
categorized as 18-21, 22-25, and 26-29 years. The education variable consisted of the 
following four categories: no formal education; some primary; some secondary; 
secondary or more. Religion referred to being Catholic, Protestant, Christian or other. 
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Employment status was categorized as employed (full or part-time) and unemployed. 
Marital status consisted of the following two categories: single and cohabitating or 
married.  
 
3.4.2 In-Depth Interview Guide  
  A semi-structured interview guide was developed based on preliminary findings 
from the quantitative phase. The topical guide for the in-depth interviews included open-
ended questions and probes in order to capture contexts in which the disclosure event(s) 
had occurred and explore gender-related motivators and barriers for disclosure. Specific 
questions and probes regarding the first disclosure included: “Tell me about the first time 
you disclosed your HIV status”, “Why did you decide to tell this person first?”, “How did 
you expect this person to react?”, and “Did you feel more or less confident to disclose to 
someone else after this first experience?” Specific questions related to disclosure to 
sexual partners included: “What made you decide to share your HIV test result with your 
partner(s)?”, “How did you decide of the right time to tell him/her?”, and “What was 
their reaction?” Additionally, the interview schedule explored reasons for not disclosing 
to anyone or to sexual partners, as well as intentions regarding disclosure in the future. 
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3.5 Data Management and Analysis  
3.5.1 Quantitative Analysis 
The quantitative survey was administered to 696 HIV-positive youth. After 
excluding 16 participants (2.3%) because of incomplete data on disclosure variables, data 
for 680 HIV-positive youth were included in the statistical analysis. Data were double-
entered using Epi-Info (version 7.1.3, Atlanta, GA, USA) and analyzed in Stata 12.0 
(StataCorp, College Station, TX, USA). 
 Four sets of analyses were conducted. First, descriptive statistics were conducted 
for the full sample and for male and female participants separately on all key variables. 
Second, HIV serostatus disclosure patterns (whom disclosed to first, second and third; 
timing of each disclosure; and reasons for disclosing) were tabulated, disaggregated by 
gender. Third, sociodemographic, health-related, psychosocial and sexual behavior 
variables were then individually assessed for their association to the main outcome of 
interest (disclosure to all sexual partners in the past 3 months) for male and female study 
participants separately. Finally, gender-specific hierarchical (or nested) multivariate 
regression modeling predicting full disclosure (HIV disclosure to all sexual partners) was 
used to examine the contribution above and beyond each group of independent variables 
that were associated with the outcome at an alpha level of 0.10 based on bivariate 
regression. In the first model of the hierarchical regression procedure, sociodemographic 
variables (age and marital status) were block entered; in the second step, HIV-related 
characteristics (time since HIV diagnosis, currently on ART, and previous disclosure to 
family) were entered into the first model. Next, partner characteristics (partner relation-
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ship type and partner HIV serostatus) were entered in order to get the third model. In the 
last step, psychosocial characteristics (HIV Acceptance, Personalized stigma, Disclosure 
stigma, Social support, Depression and Subjective norms) were entered as a block into 
Model 3. The likelihood ratio (LR) test, a measure of evaluation of the contribution of 
predictors to the base model, was used to compare two successive nested models. Akaike 
information criteria (AIC) and the Hosmer and Lemeshow test (Hosmer, Lemeshow, & 
Sturdivant, 2000) were used to assess the goodness of fit of successive models for each 
gender. All analyses were performed using logistic regression with 95% confidence 
intervals. 
 
3.5.2 Qualitative Analysis  
The in-depth interviews were transcribed verbatim in Haitian Kreyòl and 
subsequently translated into English for analysis. Transcripts were edited to remove 
identifiers and were read thoroughly multiple times. A codebook of key themes was 
developed around the main interview topics to guide the content analysis (Ulin, 
Robinson, & Tolley, 2005). Data were examined by themes, and key representative 
quotes from the transcripts were identified. The mixed methods analysis was done in a 
sequential but cohesive manner, such that data combination occurred at the level of data 
interpretation. 
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4. Results 
 
4.1 Quantitative Results 
4.1.1 Description of the Sample 
The main characteristics of the study participants are described in Table 1. The 
sample consisted of 680 HIV-positive young adults (46% male; 54% female) with an 
average age of 23.7 years (SD = 2.0) for males and 24.1 years (SD = 2.1) for females. 
Overall, more than two-thirds of the sample was between 18 and 25 years old. 81% of 
male participants had some secondary school education level compared to only 64% of 
females.  
The vast majority of participants was single (73%). More female youth (34%) 
reported cohabitation with a partner or being married than males (18%).  Approximately 
10% of males self-identified as homosexual. Sexual transmission was the main route of 
HIV acquisition for the sample (97%). At the time of interview, about half (46%) of 
participants were relatively recently diagnosed HIV-positive (less than 2 years), with 
males more likely to be recently diagnosed compared with females. A little over half of 
the overall sample (54%) was currently taking ART, with a higher proportion of females 
(60%) compared to males (48%). Alcohol and substance use were higher among males 
(41% and 23%, respectively) compared to females (14% and 12%, respectively).  
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Table 1: Sociodemographic and health characteristics of sample (N=680) 
 
Characteristic 
n (%) n (%)
Age 4.96
18 - 21 94 (29.8) 90 (24.7)
22 - 25 146 (46.2) 160 (44.0)
26 - 29 76 (24.1) 114 (31.3)
Education 28.93***
No formal 20 (6.3) 24 (6.6)
Some Primary 19 (6.0) 46 (12.7)
Some Secondary 156 (81.0) 233 (64.0)
Secondary or more 21 (6.7) 61 (16.8)
Religion 11.14*
Catholic 136 (43.0) 141 (38.7)
Protestant 81 (25.6) 92 (25.3)
Christian 79 (25.0) 122 (33.5)
Other 19 (6.0) 8 (2.2)
Employment 1.21
Employed 82 (26.9) 105 (28.9)
Unemployed 231 (73.1) 258 (70.9)
Marital status 22.25***
Single 259 (82.0) 240 (65.9)
Cohabitating/Married 57 (18.0) 124 (34.1)
Sexual orientation 42.27***
Heterosexual 283 (89.6) 361 (99.2)
Homosexual 33 (10.4)
Bisexual / Other 3 (0.8)
Time since HIV diagnosis 18.94***
Less than 2 years 169 (53.5) 142 (39.0)
2 years - 4 years 111 (35.1) 188 (51.7)
More than 4 years 36 (11.4) 34 (9.3)
Mode of HIV acquisition 2.35
Perinatally 4 (1.3) 6 (1.7)
Sexual transmission 309 (97.8) 350 (96.2)
Blood transfusion 1 (0.3) 1 (0.3)
Don't know 2 (0.7) 7 (2.0)
Currently on ART 10.43**
No 164 (51.9) 147 (40.4)
Yes 151 (47.8) 217 (59.6)
Alcohol use 66.94***
No use 186 (58.9) 311 (85.4)
Any use 130 (41.1) 50 (13.7)
Substance use 13.76***
No use 245 (77.5) 321 (88.2)
Any use 71 (22.5) 43 (11.8)
Male ( N=316) Female (N = 364)
 
                                *P < .05.  **P < .01. ***P < .001. 
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4.1.2 Sexual and Reproductive History  
The sexual history of participants is shown in Table 2. The average age at first 
sexual experience was 12.7 years (SD = 2.3) for males, compared to 15.4 (SD = 1.7) for 
females. Male youth reported two times more lifetime sexual partners than females (13.1 
partners for males compared to 5.8 for females). About 30% of participants had children, 
with female youth more likely to report any children than males. A substantial proportion 
(27% males and 22% females) had been diagnosed with a sexually transmitted infection 
(STI) other than HIV in the past 3 months. Close to half of respondents reported having 
just one sexual partner in the past 3 months. Males were more likely to report multiple 
partners, compared to females (60% vs. 40%, respectively).  The average number of 
sexual partners in the past 3 months reported was 1.7 (SD = 0.7; range: 1 - 5) for males 
and 1.4 (SD 0.5; range: 1 - 3) for females.  
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Table 2: Sexual and reproductive history characteristics of sample (N=680) 
Characteristic or t
n (%) n (%)
Age at first sex -18.02***
Mean (SD) 12.7 (2.3) 15.4 (1.7)
Number of lifetime partners 24.95***
Mean (SD) 13.1 (4.7) 5.8 (2.9)
Sexual partners in past 3 months 20.19***
One 126 (39.9) 208  (57.1)
Two or more 190 (60.1) 156 (42.9)
Partner relationship type 3.93
Casual only 189 (59.8) 203 (55.8)
Main and Casual 36 (11.4) 32 (8.8)
Main only 91 (28.8) 129 (35.4)
Partner HIV serostatus 2.06
HIV-positive only 36  (11.4) 54 (14.8)
Unknown only 190 (60.1) 217 (59.6)
HIV-negative only 90 (28.5) 93 (25.6)
STI diagnosis in last 3 months 4.41
No 230 (72.8) 283 (77.8)
Yes 86  (27.2) 79 (21.7)
Living children 31.15***
No 253 (80.1) 220 (60.4)
Yes 63 (19.9) 143 (39.3)
Male (N = 316) Female (N = 364)
 
                    *P < .05.  **P < .01. ***P < .001. 
 
4.1.3 Psychosocial Characteristics  
In this sample of young HIV-positive individuals, males experienced greater 
stigma related to personalized stigma while females experienced greater stigma related to 
disclosure concerns. Statistically significant differences in mean scores for both subscales 
were found between genders (Table 3). The overall mean CES-D depression score was 
19.8 (SD = 5.1), with female youth scoring on average 20.2 slightly above the mean score 
of 19.3 for males. However, a depression score of 23 or greater, considered an indicator 
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of probable depressive symptoms (Hays, Blazer, & Gold, 1993) was observed for 37% of 
females compared to only 26% of males. Overall, participants reported moderate 
acceptance of their HIV illness with no significant difference between genders. Higher 
levels of social support were reported by female respondents compared to males. Finally, 
participants as a whole experienced very little social pressure to disclose with a positive 
mean subjective norm score of 0.5 (SD = 5.7).  
 
Table 3: Psychosocial characteristics of sample (N = 680) 
Characteristic t statistic
Mean (SD) Mean (SD)
Personalized Stigma 5.58***
Range (18 - 72) 58.3 (7.0) 53.6 (13.3)
Disclosure Stigma -6.86***
Range (10 - 40) 28.2 (8.1) 31.5 (3.8)
Depression -2.29*
Range (0 - 60) 19.3 (4.6) 20.2 (5.5)
HIV Acceptance -1.71
Range (6 - 24) 14.3 (5.0) 15.1 (6.1)
Social Support -4.21***
Range (0 - 100) 38.7 (22.3) 45.9 (22.1)
Subjective norms -2.84**
Range (-24 to + 24) -0.14 (5.4) 1.14  (5.9)
Male (N = 316) Female (N = 364)
 
        *P < .05.  **P < .01. ***P < .001. 
 
4.1.4 HIV Disclosure Patterns  
At the time of data collection, 384 (56%) respondents had told at least one person 
about their HIV status (Table 4). A majority of female youth (70%) had disclosed to a 
family member or a friend, compared to only 35% of males. Among the youth who had 
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disclosed to at least one person (n=384), the majority had disclosed to 2 people (56%). 
Two times more female youth (24%) had disclosed to three or more people since their 
HIV diagnosis compared to males (13%).  
The overall extent of disclosure was explored within participants' friends and 
family networks. The average proportion of people in each respondent's friend network 
that was aware of his/her HIV status was 0.12 (SD = 0.25; range: 0.00 - 1.00) for males 
and 0.16 (SD = 0.30; range: 0.00 - 1.00) for females. Sixty-two percent of respondents 
had ratios of 0.00, that is, they had not disclosed to any friends compared to 5% who had 
disclosed to their entire friend network (ratio 1.00). Within the family network, the 
average proportion of people aware of respondents' HIV status was three times lower for 
males (Mean = 0.13; SD = 0.32) compared to females (Mean 0.37; SD = 0.37). Forty-
eight percent of respondents had not disclosed to any close family members (ratio 0.00) 
compared to 16% who had revealed their HIV status to all members of their family. 
Among disclosers, the majority (57%) had disclosed to their first confidant in the 
first month after diagnosis and only about 4% of youth waited over a year to disclose for 
the first time (Table 4). A larger proportion of males (67%) disclosed in the first month 
after diagnosis compared to females (52%), although females continued to display higher 
rates of disclosure up to a year after their HIV diagnosis. Most first time disclosure events 
(46%) were to someone from the close social network of family and friends, whereas 
only 18% of first disclosures were to spouses or sexual partners. Male youth were most 
likely to disclose their HIV status to their sexual partners (35%), followed by their friends 
(28%), while female youth were more likely to share the news of their HIV diagnosis 
 37 
with their mothers (51%) and sisters (27%). Fathers were infrequently used as confidants 
for both genders. 
Overall, the most frequently mentioned reasons for first disclosures included: 
emotional support (92%), financial support (70%) and medical or home care (65%). 
While both genders were seeking emotional support with their first disclosure at 
comparable levels (about 92% each), females differed significantly from males with 
regards to financial support (89% for females vs. 30% for males) and medical care (77% 
for females vs. 40% for males).  The two most frequent reasons for disclosure cited by 
young males, after emotional support were: because he/she should know (42%), and 
medical or home care (40%). Supportive reactions from first-time confidants were 
frequent (about 61%) while neutral responses were reported 33% of the time. Negative 
outcomes were rare and accounted for only 6% of the reactions to first disclosures. There 
were no significant differences between genders.  
Spouses or sexual partners were the most frequent type of confidants for second 
disclosures for both males and females (55% overall). The most frequently mentioned 
reasons for second disclosures included: emotional support (72%), because he/she should 
know (53%), and to encourage HIV testing (52%). As for first-time disclosures, confidant 
reactions were mostly supportive for both genders (67%). Of the 68 PLWHA who had 
disclosed to three or more people, the majority was female (79%). Third disclosures were 
mostly directed towards friends (68%) and were seeking primarily emotional support 
(96%). 
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Over three-quarters of the sample (76%) reported that prior discussion about 
disclosure and safe sex with their counselors at their clinic had been very limited, with no 
difference between genders. Nearly all youth (about 96%) had no intentions to disclose 
their status to anyone new in the next 3 months (Table 4). Among the 296 individuals 
(44%) who had kept their HIV status a secret from everyone in their social networks, the 
main reasons for non-disclosure included: fear of rejection (41%), fear of negative 
consequences for self (37%), and fear of blame (33%). 
Among those who disclosed to their sexual partners from the past 3 months, the 
most common motivators for disclosure were the desire to protect and encourage HIV 
testing among male respondents (49%), and the moral/ethical responsibility among 
female participants (44%).  
 
 
 
 
 
 
 
 39 
Table 4: HIV serostatus disclosure characteristics of sample (N=680) 
 
        *P < .05.  **P < .01. ***P < .001. 
 
Characteristic 
n (%) n (%)
Ever disclosed to anyone 66.15***
No 190  (60.1) 106 (29.1)
Yes 126 (39.9) 258 (70.9)
Ever disclosed to a family member 84.64***
No 207 (65.5) 110 (30.2)
Yes 109 (34.5) 254 (69.8)
Ever discussed disclosure with counselor 0.68
A lot / somewhat 70 (22.2) 90 (24.9)
A little / not at all 245 (77.8) 271 (75.1)
Disclosure intentions in next 3 months 0.15
Not at all / somewhat important 304 (96.2) 348 (95.6)
Very / extremely important 12  (3.8) 16  (4.4)
Among those who have disclosed to anyone 
n (%) n (%)
Number of people disclosed to since diagnosis 29.23***
One 51 (40.5) 41 (15.9)
Two 59 (46.8) 156 (60.5)
Three or more 16  (12.7) 61 (23.6)
Timing of first disclosure 16.06**
Within 24 hours of diagnosis 25 (19.8) 45 (17.4)
In the first month after diagnosis 84 (66.7) 135 (52.3)
1 - 6 months after 12 (9.5) 33 (12.8)
6 - 12 months after 2 (2.4) 33 (12.8)
Over 1 year after 2 (1.6) 12 (4.7)
Confidant reaction to first disclosure 2.54
Supportive 80 (63.5) 154 (59.7)
Unsupportive 10 (7.9) 13 (5.0)
Neutral 36 (28.6) 91 (35.3)
Male (N = 316) Female (N = 364)
Male (N = 126) Female (N = 258)
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4.1.5 Factors Predicting Disclosure to Sexual Partners 
Among study participants, 226 (33%) had disclosed their HIV status to all their 
sexual partners (full disclosure) in the past 3 months.  
 
4.1.5.1 Factors Predicting Disclosure to Sexual Partners Among Male Participants  
Among young adult males, 32% had disclosed their HIV serostatus to all their 
sexual partners from the past three months. Table 5 presents results of unadjusted 
bivariate and hierarchical multivariate regression analyses for factors associated with 
HIV serostatus disclosure to all sexual partners among male participants. Bivariate 
analyses revealed that younger age, higher levels of personalized and disclosure stigma 
were significantly associated with lower odds of disclosure to all sexual partners (P < 
0.001 for all variables). Male respondents with casual or a mix of main and casual 
partners in the past three months, and those who were unaware of their partners’ HIV 
status were less likely to have disclosed their status compared to those with main partners 
only (P < 0.001) and those with knowledge of their partners’ status (P < 0.001). Conver-
sely, being married or cohabitating with a partner, longer period of time since HIV 
diagnosis, previous disclosure to family, increased acceptance of HIV, higher levels of 
social support and depression were associated with greater odds of HIV serostatus 
disclosure to all sexual partners, among HIV-positive males. 
The results of the hierarchical regression modeling predicting full disclosure to 
sexual partners from demographic, HIV-related, partner and psychosocial characteristics 
among male participants are also reported in Table 5. Model 1 presents the relationship 
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between demographic variables and full disclosure to sexual partners from the past 3 
months. Younger and older age categories were significantly less likely to disclose their 
HIV status compared to the 22-25 age group. Conversely, married or cohabitating male 
respondents were over 11 times more likely than single males to self-report disclosure to 
all sexual partners. In Model 2, HIV-related characteristics were added to the baseline 
demographics-only model. Having an average duration since HIV diagnosis of 2 to 4 
years and having previously disclosed to family were significantly associated with greater 
odds of disclosure. Demographic variables remained statistically significant once the 
HIV-related variables were included in this model. Partner variables were added to the 
demographics and HIV-related characteristics model in order to obtain Model 3. Having 
casual partners and partners of unknown HIV status were significantly associated with 
lower odds of disclosure. Among variables entered in previous models, only being older 
(26-29 years) remained significantly associated with full disclosure once the partner 
variables were entered into the model. 
The final model (Model 4) added psychosocial variables to Model 3. Increased 
HIV acceptance (AOR = 1.67, 95% CI: 1.06, 2.62) and higher personalized stigma (AOR 
= 1.26, 95% CI: 1.00, 1.58) were significantly associated with greater odds of disclosure, 
whereas higher disclosure stigma (AOR = 0.51, 95% CI: 0.34, 0.77) was significantly 
associated with lower odds of full disclosure. The only variables that remained significant 
predictors of disclosure once the psychosocial characteristics were added included older 
age (AOR = 0.00, 95% CI: 0.00, 0.31), being unaware of partners' HIV status (AOR = 
0.00, 95% CI: 0.00, 0.05), and having HIV-negative partners (AOR = 0.01, 95% CI: 0.00, 
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1.01). Additionally, Model 4 had a significantly reduced log-likelihood compared to 
previous models, suggesting that the final model explained more of the variance in the 
outcome (P < 0.001). The Hosmer and Lemeshow test also suggested that this model was 
a good fit to the data as P = 0.689 (> 0.05).  
 
 
 
  
4
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Table 5: Bivariate and Hierarchical regression analyses evaluating factors predicting full disclosure to sexual partners among 
male participants (n = 316) 
Crude OR 95% CI P-value Adj OR 95% CI P-value Adj OR 95% CI P-value Adj OR 95% CI P-value Adj OR 95% CI P-value
Demographics
Age
18 - 21 0.13 0.06, 0.29 <0.001 0.15 0.06, 0.34 <0.001 0.25 0.10, 0.67 0.005 0.72 0.07,6.91 0.779 0.71 0.01, 58.15 0.879
22 -25 Ref - - Ref - - Ref - - Ref - - Ref - -
26 - 29 0.86 0.49, 1.52 0.602 0.28 0.12, 0.64 0.002 0.11 0.04, 0.32 <0.001 0.02 0.00, 0.15 <0.001 0.00 0.00, 0.01 0.001
Marital status
Single Ref - - Ref - - Ref - - Ref - - Ref - -
Cohabitating/Married 11.39 5.81, 22.32 <0.001 15.37 6.59, 35.84 <0.001 16.05 6.32, 40.77 <0.001 2.33 0.43, 12.73 0.327 0.35 0.00, 26.41 0.634
HIV-related characteristics
Time since HIV diagnosis
Less than 2 years Ref - - Ref - - Ref - - Ref - -
2 years - 4 years 4.39 2.55, 7.55 <0.001 2.55 1.25, 5.20 0.010 0.73 0.15, 3.64 0.706 1.26 0.04, 42.87 0.899
More than 4 years 2.95 1.35, 6.42 0.006 0.90 0.25, 3.20 0.871 0.40 0.06, 2.57 0.336 1.41 0.03, 61.27 0.858
Currently on ART
No Ref - -
Yes 0.76 0.47, 1.23 0.272
Previous disclosure to family
No Ref - - Ref - - Ref - - Ref - -
Yes 4.76 2.57, 8.81 <0.001 9.43 3.69, 24.11 <0.001 4.00 0.98, 16.36 0.054 2.53 0.13, 50.27 0.543
Partner characteristics
Partner relationship type
Casual only 0.00 0.00, 0.01 <0.001 0.03 0.00, 0.18 <0.001 0.11 0.00, 2.45 0.166
Main and casual 0.22 0.09, 0.52 0.001 0.32 0.06, 1.62 0.171 0.35 0.01, 12.11 0.566
Main only Ref - - Ref - - Ref - -
Partner HIV serostatus
HIV-positive only Ref - - Ref - - Ref - -
HIV unknown 0.00 0.00, 0.01 <0.001 0.00 0.00, 0.04 <0.001 0.00 0.00, 0.05 0.008
HIV-negative 0.21 0.06, 0.75 0.016 0.44 0.07, 2.72 0.379 0.01 0.00, 1.01 0.050
Psychosocial characteristics
HIV Acceptance 1.38 1.29, 1.49 <0.001 1.67 1.06, 2.62 0.025
Personalized Stigma 0.94 0.91, 0.97 <0.001 1.26 1.00, 1.58 0.047
Disclosure Stigma 0.76 0.72, 0.81 <0.001 0.51 0.34, 0.77 0.001
Social Support 1.04 1.03, 1.05 <0.001 1.02 0.98, 1.07 0.326
Depression 1.07 1.01, 1.13 0.016 0.89 0.67, 1.18 0.421
Subjective norms 0.97 0.93, 1.02 0.283
-2LL 300.2912 271.7508 89.4370 33.6180
Likelihood ratio test 90.3, df = 3, p<0.001 28.54, df = 3, p<0.001 182.31, df = 4, p<0.001 55.82, df = 5, p<0.001
AIC 308.2912 285.7509 111.4371 65.6192
Hosmer and Lemeshow chi-square 2.79, df = 4, p = 0.593 3.89, df = 6, p = 0.691 3.91, df = 6, p = 0.689
Model 1 Model 2 Model 3 Model 4 Unadjusted 
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4.1.5.2 Factors Predicting Disclosure to Sexual Partners Among Female Participants 
 Among young adult females, 34.3% had disclosed their HIV serostatus to all their 
sexual partners in the past three months. Table 6 presents results of unadjusted bivariate 
and hierarchical multivariate regression analyses for factors associated with HIV 
serostatus disclosure to all sexual partners of female participants. Similar to their male 
counterparts, bivariate analyses revealed that being single, higher levels of personalized 
and disclosure stigma, having casual sexual partners, and partners of unknown or HIV-
negative status were significantly associated with reduced likelihood of HIV disclosure to 
all sexual partners (P < 0.05 for all variables) among HIV-positive females. Additionally, 
younger (18-21 years) and older (26-29 years) age categories were significantly 
associated with lower odds of disclosure. Conversely, female respondents who had 
previously disclosed to family and who self-reported higher levels of HIV acceptance and 
social support were significantly more likely to disclose to their sexual partners (Table 6). 
Contrary to males, depressive symptomatology was negatively associated with disclosure 
among females (P = 0.011) and time since HIV diagnosis was not associated with 
disclosure. 
The results of the hierarchical regression modeling predicting full disclosure to 
sexual partners from demographic, HIV-related, partner and psychosocial characteristics 
among female participants are also reported in Table 6. Model 1 presents the relationship 
between demographic variables and full disclosure to sexual partners from the past 3 
months. Older and single females were significantly less likely to disclose their HIV 
status compared to the 22-25 age group and those who were cohabitating or married. In 
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model 2, HIV-related characteristics were added to the baseline demographics-only 
model. Those who had previously disclosed to family were close to 10 times more likely 
to have disclosed to their sexual partner(s). Only being single remained statistically 
significant among the demographic variables once the HIV-related characteristics were 
included in this model. Partner variables were added to the demographics and HIV-
related characteristics model in order to obtain Model 3. Having casual partners and 
partners of unknown HIV status were significantly associated with lower odds of 
disclosure. Among variables entered in previous models, being older (26-29 years), being 
single, and previous disclosure to family remained significantly associated with full 
disclosure once the partner-level characteristics were entered into the model.  
The final model (Model 4) added psychosocial variables to Model 3. Higher 
personalized stigma (AOR = 0.92, 95% CI: 0.88, 0.96) was significantly associated with 
lower odds of disclosure, whereas increased social support (AOR = 1.04, 95% CI: 1.01, 
1.08) was significantly associated with higher odds of full disclosure. The variables that 
remained significant predictors of disclosure once the psychosocial characteristics were 
added included older age (AOR = 0.07, 95% CI: 0.02, 0.34), being single (AOR = 0.08, 
95% CI: 0.02, 0.31),  having casual or a mix of main and casual partners (AOR = 0.02, 
95% CI: 0.00, 0.16, and AOR = 0.03, 95% CI:  0.01, 0.15 respectively), and being 
unaware of partners' HIV status (AOR = 0.09, 95% CI: 0.01, 0.68). Moreover, Model 4 
had a significantly reduced log-likelihood compared to previous models, suggesting that 
the final model explained more of the variance in the outcome (P < 0.001). The Hosmer 
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and Lemeshow test also suggested that only Model 4 provided a good fit to the data with 
P = 0.818 (> 0.05).
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Table 6: Bivariate and Hierarchical regression analyses evaluating factors predicting full disclosure to sexual partners among 
female participants (n = 364) 
 
Crude OR 95% CI P-value Adj OR 95% CI P-value Adj OR 95% CI P-value Adj OR 95% CI P-value Adj OR 95% CI P-value
Demographics
Age
18 - 21 0.30 0.16, 0.56 <0.001 0.43 0.18, 1.03 0.059 0.50 0.20, 1.25 0.140 0.44 0.12, 1.58 0.207 0.35 0.07, 1.66 0.185
22 - 25 Ref - - Ref - - Ref - - Ref - - Ref - -
26 - 29 0.43 0.25, 0.73 0.002 0.26 0.12, 0.56 0.001 0.48 0.21, 1.10 0.084 0.20 0.06, 0.64 0.006 0.07 0.02, 0.34 0.001
Marital status
Single 0.02 0.01, 0.05 <0.001 0.02 0.01, 0.04 <0.001 0.03 0.01, 0.06 <0.001 0.09 0.03, 0.28 <0.001 0.08 0.02,0.31 <0.001
Cohabitating/Married Ref - - Ref - - Ref - - Ref - - Ref - -
HIV-related characteristics
Time since HIV diagnosis
Less than 2 years Ref - -
2 years - 4 years 1.32 0.82, 2.11 0.256
More than 4 years 0.55 0.21, 1.42 0.215
Currently on ART
No Ref - -
Yes 0.78 0.50, 1.23 0.287
Previous disclosure to family 
No Ref - - Ref - - Ref - - Ref - -
Yes 17.65 6.96, 44.76 <0.001 9.43 3.17, 28.09 <0.001 6.67 1.72, 25.78 0.006 2.45 0.45, 13.44 0.302
Partner characteristics
Partner relationship type
Casual only 0.00 0.00, 0.01 <0.001 0.01 0.00, 0.07 <0.001 0.02 0.00, 0.16 <0.001
Main and casual 0.28 0.12, 0.62 0.002 0.08 0.02, 0.28 <0.001 0.03 0.01, 0.15 <0.001
Main only Ref - - Ref - - Ref - -
Partner HIV serostatus 
HIV-positive only Ref - - Ref - - Ref - -
HIV unknown 0.01 0.00, 0.03 <0.001 0.14 0.03, 0.66 0.013 0.09 0.01, 0.68 0.019
HIV-negative 0.03 0.01, 0.11 <0.001 0.64 0.12, 3.23 0.587 0.48 0.07, 3.32 0.460
Psychosocial characteristics
HIV Acceptance 1.18 1.13, 1.23 <0.001 1.04 0.86, 1.25 0.678
Personalized Stigma 0.91 0.89, 0.92 <0.001 0.92 0.88, 0.96 <0.001
Disclosure Stigma 0.73 0.67, 0.81 <0.001 0.96 0.85, 1.09 0.533
Social Support 1.03 1.01, 1.04 <0.001 1.04 1.01, 1.08 0.017
Depression 0.95 0.91, 0.99 0.011 0.95 0.87, 1.04 0.253
Subjective norms 0.98 0.94, 1.02 0.260
-2LL 248.8930 226.6842 127.5838 99.7714
Likelihood ratio test 197.16, df = 3, p < 0.001 22.21, df = 1, p < 0.001 99.10, df = 4, p < 0.001 27.81, df = 5, p < 0.001
AIC 256.893 236.684 145.584 127.771
Hosmer and Lemeshow chi-square 14.75, df = 6, p = 0.022 23.68, df = 7, p = 0.001 4.41, df = 8, p = 0.818
Model 1 Model 2 Model 3 Model 4 Unadjusted 
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4.2 Qualitative Results  
4.2.1 Description of the Sample 
A subset of twelve individuals (five males and seven females), ranging in age 
from 19 to 28 years (mean age 24 years) participated in the qualitative interviews. Six of 
the participants were cohabitating or married at the time of the interview (2 males and 4 
females). Although some participants had been diagnosed with HIV for as little as 8 
months, others had known their HIV status for as long as two and a half years (median 
time since diagnosis was 15 months).  The majority (9/12) were unemployed. The 
breakdown by gender, age and marital status in the qualitative subsample mirrored that of 
the larger quantitative sample; however, participants with a history of disclosure (7/12) 
were oversampled in order to allow a broader exploration of factors linked to decisions to 
disclose.  
Qualitative findings shed light on how youth decided to disclose or not disclose 
their HIV status, to whom they chose to disclose, and the reactions of their confidants.    
 
4.2.2 Deciding to Disclose Their HIV Status 
After learning of their HIV-positive diagnosis, all participants faced the tough 
decision of whether, how and to whom to disclose their status. Participants acknowledged 
that the anxiety over whether to disclose was taxing and that making the decision to 
disclose was one of the most difficult steps after learning of their diagnosis. Most 
recounted experiencing apprehension and stress not knowing whether their confidants 
would respond positively or would reject them.  There was a wide range of disclosure 
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patterns between the seven participants who had disclosed their HIV status. All had 
shared their diagnosis with at least one person and most (71%) had told more than one 
person. They typically disclosed first to family or friends. Among the three males who 
had disclosed, only one had disclosed to his sexual partners. All but one of the four 
females who had disclosed shared their HIV diagnosis with a family member first. The 
young woman who disclosed to a sexual partner first reported having no close friends or 
relatives. Two of the women had disclosed to their sexual partners.  
Most participants who had disclosed shared that they had disclosed their status to 
someone in their family because of a need for emotional or financial support and to feel 
less isolated. While most disclosed within the first month after diagnosis, two participants 
said that it took over one year for them to have enough courage to disclose to their 
families. Patterns of disclosure to family mirrored quantitative patterns of expected 
emotional and economic support for both male and female participants, especially those 
who were younger. One 19-year-old male youth expressed the following: "I told my 
mother because she is all I have and I need her support." A married female (24 years old) 
echoed the same feeling regarding her partner: "I lost all my family in the big earthquake. 
He [husband] is the only one supporting me even if I know he infected me." 
Disclosure to sexual partners was perceived as one of the most difficult disclosure 
experiences by all participants, regardless of whether they had ever disclosed to a partner 
or not. For the three participants who had disclosed to sexual partners (2 females and 1 
male), motivations for disclosure to partners were different than those for disclosing to 
family members. They recounted disclosing to their sexual partners as a way to 
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encourage them to get tested and encourage future condom use. Both females in 
particular expressed that they disclosed out of a sense of moral duty because their partner 
“deserved to know”. The sole male participant who had disclosed to his sexual partner 
shared that the need for emotional support and help with medical care prompted him to 
share his diagnosis with his partner, especially since he had been previously rejected by 
his family after telling them the news. The 18-year-old male expressed the following: “I 
told my mom and my dad. They kicked me out on the street. I had nowhere to go. She 
[girlfriend] took me in even though she is HIV-negative and has been my greatest source 
of support. I love her for that.”  
 
4.2.3 Deciding to Keep Their HIV Status a Secret 
 At the time of the interviews, five participants (2 males and 3 females) had not 
disclosed their status to anyone.  When asked for reasons for not disclosing to anyone, all 
cited fear of stigma and rejection. Additionally, fear of blame, gossip and subsequent 
unauthorized disclosures were also mentioned by both males and females as factors 
hindering disclosure. For most of those non-disclosers, both the fear of being stigmatized 
by others and self-stigma played an important role in their decision to keep their secret. 
One 19-year-old female expressed the following: “I feel worthless [long silence]. I keep 
telling myself that my blood is bad, I am bad. I don’t know why this happened to me 
[participant crying].” One 24-year-old male had still not come to terms with his HIV 
status even though he received his results over 14 months before the date of the 
interview: “How could I have it [HIV]? I will never live a normal life with this thing.” 
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 When asked about the barriers to disclosure to their sexual partners, the 
participants who had not disclosed to sexual partners said they were concerned with their 
partners’ reaction to the news. For young men, this fear was fueled by the possible 
exposure of their unfaithfulness, whereas for young women, this apprehension reflected 
not only the perceived anticipated loss of economic support but also anxiety over 
abandonment and physical abuse. For females, the fear of disclosing to sexual partners 
was persistent even after they had already disclosed and secured support from family 
members. As one unmarried 24-year old female expressed: “Yes, my mom and sister 
know [about my status]. They console me when I am sad because I can’t tell my partner. 
He will leave me. How will I feed myself and our child? How will I be able to take care 
of my mom if he leaves?” Another female participant said that she would never disclose 
to her partner because of the fear of being “blamed as the source of the infection”. 
 
4.2.4 Choosing Whom to Disclose To 
Of those who did disclose to family (2 males and 3 females), the most common 
person disclosed to was a mother or a sister.  One overarching theme that crossed gender 
lines was the selectivity in the choice of confidant. Among those who had disclosed to 
family or friends, none had disclosed to their entire circle of family or friends. All 
participants selectively chose who among their inner circle of family or friends was 
worthy of their trust and limited their disclosure to only these people. One important 
aspect of choosing and trusting this confidant was the assurance that the secret would be 
kept safe. Both males and females viewed selective disclosure as an approach to protect 
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loved ones from potentially distressing news. A 25-year-old male said: “I will never tell 
my mother. She would die if she learned this news. She is counting on me to support her 
through her old days.” People who were perceived as having always been supportive, 
accepting and most importantly who could handle the upsetting news were disclosed to 
selectively. 
The same selectivity in the choice of confidant held true for disclosure to sexual 
partners. The decision to disclose was often based on the nature, quality and seriousness 
of the relationship. Participants who were involved in casual relationships did not feel the 
need to disclose to their partners, as long as they were using protection. “I insist on using 
condoms. Why should I tell him? We will probably never get married anyway”, said a 
20-year old female. Another important factor for choosing whom to disclose to was the 
confidant’s own HIV status, as one 26-year old female shared: “He [current partner] is 
HIV-positive like me. We met at a support group. We help each other a lot and I can be 
myself with him.”  
 
4.2.5 Disclosure Outcomes 
Most participants who had disclosed their HIV status to family, friends, or sexual 
partners reported at least one compassionate reaction. One 24-year-old woman recalls 
that her husband was very calm after she told him the news. “I told him I had tested 
positive for HIV. He said nothing for a long time, then said that he would be there for me. 
I asked him to go get tested. He refused. It’s been 2 years [long pause]. I believe he is the 
one who infected me because he refuses to use condoms.” She went on to explain how 
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difficult it had been to negotiate safe sex with him, prior to her testing HIV-positive, 
because of her financial dependence on him. 
Only two participants recounted an adverse reaction to their disclosure. One was 
an 18-year-old male who shared the following: “My family kicked me out in the streets 
saying that I was a source of shame for all of them”. The other (a female) suffered 
physical abuse from her partner before he left her for another woman. Regardless of their 
confidant’s reaction to disclosure, all participants described feeling liberated, as if “an 
enormous weight had been lifted off their backs” after disclosing their result.  
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5. Discussion 
 
5.1 Reflection on HIV Serostatus Disclosure Among Young 
Adults: Rates, Patterns and Predictors 
This study described the patterns of HIV serostatus disclosure to family, friends, 
and sexual partners, and examined the predictors of HIV serostatus disclosure to all 
sexual partners from the past three months among 680 HIV-positive young adults 
randomly selected from six clinics in the metropolitan area of Port-au-Prince, Haiti. Just 
over half of respondents had disclosed to at least one person. A majority of female youth 
(70%) disclosed to a family member or a friend, compared to only 35% of males. This 
finding is consistent with results reported elsewhere with family members being the most 
frequent group disclosed to (Patel et al., 2012) and men being more reluctant to disclose 
to family and friends compared to women (Bouillon et al., 2007). Higher levels in general 
disclosure have been observed in other settings in the Caribbean or Africa, where rates 
have been as high as 70%  (Bouillon et al., 2007) and  94% (Deribe, Woldemichael, 
Wondafrash, Haile, & Amberbir, 2008).  It is possible that disclosure rates were 
relatively low in the Haitian setting because of a combination of factors including the 
younger age of participants, their lack of self-efficacy for disclosure given the very 
limited disclosure-specific counseling received from health care providers at the selected 
clinics, and the pervasiveness of HIV-related stigma in their communities.  
The overall HIV disclosure rate of 33% to all sexual partners in this sample is 
comparable to HIV disclosure rates observed in a previous study conducted in Haiti 
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among HIV-positive alcohol users (Conserve et al., 2014) and also similar to disclosure 
rates among immigrant Haitian communities in the French Antilles (Bouillon et al., 
2007). This low rate could be explained by possible self-stigma among Haitian nationals 
resulting from decades-old entrenched stereotypes constructing HIV as a "Haitian" illness 
(Farmer, 2001; Loufty et al., 2012). Nonetheless, comparably low rates of HIV disclosure 
to sexual partners have been found in settings in sub-Saharan Africa. Olley and collea-
gues (2004) found that only 22% of recently HIV-positive women and men in South 
Africa had disclosed to a sexual partner while 31% of female PLWHA from a mother-to-
child  HIV transmission prevention program in Kenya had disclosed to their sexual 
partner (Gaillard et al., 2002).    
In the current sample, there was no significant difference in the rate of disclosure 
to sexual partners between genders. This finding is similar to that found in Ethiopia 
(Deribe et al., 2009) but differs from another study conducted in South Africa, which 
found that male gender was associated with non-disclosure of HIV status (Simbayi et al., 
2007). In general, studies considering HIV disclosure in both men and women in 
different settings have produced mixed results (Kalichman et al., 2003; O’Brien et al., 
2003). Although gender differences were not apparent in the overall rates of disclosure to 
sexual partners in this sample, hierarchical multivariable regression analysis allowed for 
the identification of a separate set of predictor variables for each gender. 
Age was a significant predictor of HIV serostatus disclosure to all sexual recent 
partners for both genders. Older youth (26-29 years) were significantly less likely to 
disclose their HIV status to all of their sexual partners compared with younger 
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individuals, supporting similar findings from another study conducted in Haiti (Conserve 
et al., 2014). Likewise, in two studies conducted in an African setting, it was found that 
younger women (under the age of 24 years) were more likely to disclose to sexual 
partners than older women (Farquhar, et al., 2000; Gaillard et al., 2002). No association 
between age and disclosure to sexual partners was found in another investigation of HIV 
serostatus disclosure among MSM in casual relationships (Serovich & Mosack, 2003).  
The finding from the current study may be due to the fact that older participants may 
have had adverse experiences related to previous disclosures, have more casual 
partnerships than younger participants, or due to beliefs that disclosure is not essential, 
especially if they are on ART or have been on ART for longer periods of time compared 
to younger participants. Further studies are needed to elucidate the relationship between 
age and disclosure. 
Previous research has shown that PLWHA are more likely to disclose their status 
to primary partners than casual partners (D’Angelo et al., 2001; Deribe et al., 2008; 
Przybyla et al., 2013; Vu et al., 2012). In this sample, only female participants who had 
casual partners or who reported having multiple sexual partners of different types (main 
and casual) were less likely to disclose their status to their partners compared to those 
with a main partner. This finding was further emphasized in the qualitative interviews 
where female participants described how the decision to disclose was often based on the 
nature, quality and seriousness of the relationship with their partners. Interestingly, the 
type and nature of the relationship with partner(s) was not significantly associated with 
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disclosure in the final male-only model; this may be due to the predominance of multiple 
concurrent partnerships in the male study population.  
Individuals of both genders who reported being unaware of their partners’ HIV 
status were significantly less likely to have disclosed their status to their partners 
compared to those who knew their partners’ test results in the final adjusted models. 
Additionally, the highest odds of disclosure were observed among participants with HIV-
positive partners. These findings support previous research conducted in many settings 
(Conserve et al., 2014; King et al., 2008; Przybyla et al., 2013; Simbayi et al., 2007). 
PLWHA sometimes choose sero-concordant partners to reduce stress and avoid the 
potential for rejection that might occur when disclosing to HIV-negative partners 
(Parsons, VanOra, Missildine, Purcell, & Gomez, 2004). In this population, serosorting 
behavior was likely facilitated by attending support group meetings, as was described in 
the qualitative interviews. It should also be noted that 62% of participants reported 
having one or several partners of unknown HIV serostatus, with an overall 67% non-
disclosure rate. This is of particular concern, because research has shown that PLWHA 
who were unaware of their partners’ HIV status were more likely to engage in sexual 
transmission risk behaviors, putting their partners at risk of infection or re-infection 
(Conserve et al., 2014; King et al., 2008; Przybyla et al., 2013).  
The importance of social support from family and friends was highlighted in both 
the quantitative and qualitative components of this study, particularly for female parti-
cipants. Using poignant ethnographic life stories from case studies with HIV-positive 
individuals, Whetten and Pence (2013) underlined the complexity of the relationship 
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between study participants and their families in the Deep South of the United States; 
however, in most cases, participants who had disclosed to a family member had received 
emotional support and much-needed help in future decision-making (p.150). Other recent 
qualitative studies conducted in Zimbabwe and South Africa found that family members 
played a similar role in providing emotional support, helping PLWHA come to terms 
with their HIV diagnosis, and assisting them in sharing their HIV diagnosis with others 
(Maman, van Rooyen, & Groves, 2013; Zamudio-Haas, Mudekunye-Mahaka, Lambdin, 
& Dunbar, 2012). Comparable results were found in the quantitative component of the 
present study since HIV-positive Haitian females who had increased social support were 
significantly more likely to disclose to sexual partners. The directionality of this 
relationship is not clear however. Previous research has examined social support as a 
predictor (Perry, Card, Moffatt, Ashman, & Jacobsberg, 1994) or more recently as a 
mediator of disclosure (Kalichman et al., 2003). It is probable that there is a bi-directional 
relationship between social support and disclosure, such that availability of social support 
would facilitate disclosure, and that disclosure would garner even more or less social 
support. The relationship between social support and disclosure can better be assessed 
with prospective and longitudinal studies.   
Data from this study show that disclosure stigma (concerns about issues related to 
disclosing or hiding one’s HIV status) was a barrier to the revelation of HIV status 
among males, whereas higher personalized stigma was a significant factor hindering 
disclosure among females. These findings are similar to other studies among PLWHA in 
developing countries, where fear of stigma and discrimination reduced the willingness to 
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disclose HIV status (Dias, Matos, & Goncalves, 2006; Medley et al., 2004; Simbayi et 
al., 2007). In this sample, the desire to control information and the worry that those who 
were aware of respondents' HIV status would tell others (Berger et al., 2001) were among 
the strongest predictors of reduced likelihood of disclosure among males. On the other 
hand, personalized stigma was a significant barrier to disclosure because of female 
participants' perceived negative consequences of disclosure including loss of support and 
rejection. Interestingly, higher personalized stigma was found to be associated with 
greater odds of disclosure among males. This finding may be related to a duality between 
the perceived negative consequences of disclosure and the desire to protect one’s partner, 
as the majority of males in monogamous relationships in this sample cited the desire to 
protect their loved one from HIV as the main reason for disclosure. These gendered 
differences in perception of stigma and rejection also found support in the qualitative 
narratives.  
Qualitative data highlighted important contextual differences in the way male and 
female young HIV-positive adults approached non-disclosure of their HIV status. On the 
one hand, male youth, especially those with multiple sexual partners, viewed non-
disclosure as a protection against gossip about their tumultuous indiscretions and 
discovery of their unfaithfulness. On the other hand, some narratives from female 
participants recounted their inner struggles with the decision to disclose or not and how 
their fear of abandonment and fear of loss of economic support was the main barrier to 
disclosure to their partner. Research in Tanzania found similar results; HIV-positive 
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pregnant women who depended on their partner for food, rent or school fees were less 
likely to disclose their HIV status to their partner (Maman et al., 2003).  
 
5.2 Cultural Context of Study Findings 
It is important to consider the cultural context of this study's findings. First, Haiti 
is the poorest country in the Western hemisphere with a very low gross national income 
per capita of $560 and 80% of the population living below the poverty level (World 
Bank: Haiti, 2013). Second, multiple sexual partnerships are considered a social and 
cultural norm for men in Haiti (Hempstone et al., 2004). "Plasaj" is a long-term 
relationship with an unmarried partner and is very common in Haiti (Fawzi et al., 2010; 
Haiti DHS, 2012). Women who enter "plasaj" to support themselves and their children 
are particularly vulnerable because the lack of economic resources limits their ability to 
negotiate condom use and reduces their decision-making power (Rodrigo & Rajapakse, 
2010). In "plasaj", while women are usually monogamous, men are usually "in plasaj" 
with several women at the same time.  Third, gender inequality due to limited literacy 
and educational attainment among Haitian women increases their economic vulnerability 
compared to their male counterparts (Farmer, Connors, & Simmons, 1996). Given this 
pervasive gender inequality and severe economic adversity, women's economic security 
often entirely relies upon their partners' income-generating activities (Fawzi et al., 2010; 
Fitzgerald et al., 2000; Fitzgerald et al., 2004) or on economic survival strategies 
involving transactional or commercial sex, especially among young women (Dorjgochoo, 
et al., 2009; Reynolds, Beauvais, Lugina, Gmach, & Thomsen, 2010). It is possible that 
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the cultural, psychosocial and structural challenges deterring women from initially 
protecting themselves from HIV are the same factors that continue making them 
vulnerable once they are infected (Amaro, 1995; Zierler & Krieger, 1997).  
The findings from this study lend support to the Disclosure Processes Model 
(DPM) (Chaudoir et al., 2011) according to which disclosure begins with a decision-
making process based on antecedent goals which can be assimilated to forces promoting 
disclosure or concealment. The psychosocial and relational constructs measured in this 
population represent approach- and avoidance-focused goals. In this way, partner 
relationship type, partner HIV serostatus, acceptance of HIV, and social support, can be 
thought of as forces promoting disclosure. Conversely, stigma and depression can be 
considered as forces promoting concealment among this HIV-positive population. 
Finally, previous disclosure to family helped to assess the potential effect of disclosure on 
future disclosure events, through the feedback loop mechanism of the DPM.   
 
5.3 Implications for Counseling and Prevention Programming  
One of the goals of this study was to elucidate rate and patterns of HIV serostatus 
disclosure among HIV-positive youth in Haiti, in order to identify potential actions for 
secondary HIV prevention programming. The majority of participants indicated that they 
had had little or no time spent talking with clinic counselors about HIV disclosure. A 
previous study found that the rates of disclosure increased with the number of times that a 
health professional discussed issues of disclosure (De Rosa, & Marks, 1998). Similarly, 
in a qualitative study conducted at a voluntary counseling and testing clinic (VCT) in 
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Tanzania, both men and women mentioned the important role that counselors played in 
their decision to disclose (Maman, Mbwambo, Hogan, & Kilonzo, 2001). This suggests 
that counseling protocols should be adapted in order to include and reinforce discussions 
about disclosure. Therefore, specific training should be provided to HIV counselors and 
support group moderators in order to provide them with the skills necessary to talk about 
these important issues with this HIV-positive population and provide ongoing support. 
Counselors also need to be trained in the use of short culturally-adapted screening 
questionnaires to identify young PLWHA with depressive symptomatology or who are 
affected by HIV-related stigma, in order to offer or refer to appropriate services 
(Fitzgerald et al., 2004). 
Other efficacious interventions include motivational interviewing and role playing 
exercises. Motivational interviewing is a promising intervention addressing behavior 
change which supports and encourages patients to change behaviors by exploring 
different options (Naar-King et al., 2006; Yeagley et al., 2012). Using role plays, 
counselors can also help PLWHA develop the communication skills necessary for 
disclosure as well as personal disclosure plans, in order to increase perceived self-
efficacy for disclosure (World Health Organization, 2003). These two interventions can 
be tailored to the Haitian context to help HIV-positive youth aptly face the challenges of 
disclosure in their lives.   
This study indicated that family can play an important role in helping HIV-
positive youth, especially females, in coping with their diagnosis before disclosing to 
others. Therefore, HIV prevention programs should attempt to reach family members of 
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HIV-positive youth and include them in the counseling process. Other studies have 
shown that involvement of the family is extremely important and can have beneficial 
effects for future disclosure (Maman et al., 2013; Serovich, Craft, & Reed, 2012). 
However, this should be done in complete collaboration with the HIV-positive individual 
in order to avoid breaches of confidentiality and unauthorized disclosures. 
While prevention services need to be reinforced in general for all HIV-positive 
youth, a special emphasis should be placed on individuals who would particularly benefit 
from these interventions. As suggested by the study findings, young PLWHA with casual 
or multiple partners and those who are unaware of their partners’ HIV status should be 
the focus of more targeted interventions in order to reduce transmission risk behaviors, 
while tailoring interventions to address the gender-specific barriers that each face with 
regards to HIV disclosure. HIV-related stigma remains a significant barrier to disclosing 
one’s HIV status (King et al., 2008; Osinde et al., 2012; Przybyla et al., 2013) and has 
been shown to be widespread in Haiti (Castro & Farmer, 2005; Fitzgerald et al., 2004; 
Surkan et al., 2010). Therefore, community-based programs addressing pervasive gender 
norms and social attitudes about HIV need to be reinforced in order to reduce HIV-
related stigma (World Health Organization, 2003). Finally, programs and policies aiming 
to improve the economic and social status of women, such as literacy programs, income-
generating activities and access to micro-credit, can help reduce the vulnerability of 
young women and empower them to make the right decisions for their lives (Fawzi et al., 
2010). 
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5.4 Limitations 
The findings of this study must be considered in light of several limitations. First, 
this study was cross-sectional and did not allow for exploration of causative relationships.  
It would be useful to investigate the relationship between disclosure to sexual partners 
and potential predictors prospectively to determine directionality and examine if 
differences remain stable over time and across relationships. Additionally, the sample 
was selected among HIV-positive youth receiving services at clinics, and it is unclear to 
what extent this group may be representative of other PLWHA not enrolled in a program. 
Third, we relied on self-reports of disclosure to sexual partners and recent sexual 
behavior. The sensitive nature of HIV may have led to social desirability bias in the 
responses.  Also, some constructs like depression were measured using scales that were 
not culturally-adapted and validated specifically for the Haitian setting; possible cultural 
idiomatic differences should be taken into account. Despite these limitations, this study’s 
findings can serve as snapshot of HIV disclosure rates and gender-specific predictors of 
disclosure among this population and have implications for interventions targeting young 
PLWHA in Haiti or in other similar settings. 
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6. Conclusion 
The prevalence of HIV serostatus disclosure among HIV-positive youth in Port-
au-Prince is among the lowest compared to rates in other settings across both developing 
and developed countries.  The findings of the present study highlight the importance of 
addressing HIV-related stigma, enhancing communication between sexual partners, 
addressing factors related to nondisclosure, and  adapting counseling protocols to the life 
context of young PLWHA, for example by putting greater emphasis on gaining social 
support to facilitate future disclosures.  Although there were no gender differences in the 
overall prevalence of HIV serostatus disclosure to sexual partners in this sample, the 
study findings suggest that interventions targeting disclosure may be more effective to the 
extent that they adopt gender-specific approaches in HIV counseling in order to address 
barriers of disclosure.   
Further research is necessary to better understand the process and outcomes of 
HIV serostatus disclosure to sexual partners, the perceptions and attitudes of health care 
providers towards HIV disclosure, as well as the relationship between HIV serostatus 
disclosure and transmission risk behaviors in this young HIV-positive population. 
Although HIV serostatus disclosure is a daunting challenge for people living with 
HIV/AIDS (PLWHA), research conducted in multiple settings has shown that its 
beneficial effects far outweigh the potential negative implications, thus providing strong 
evidence for encouraging HIV serostatus disclosure in all HIV-positive populations. This 
is especially the case for HIV-positive young adults in Haiti, who have the most to gain 
from increased social support, reduced HIV-related stigma, and changing cultural norms 
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to reduce number and concurrency of sexual partners. HIV prevention programs should 
assist youth living with HIV in making effective decisions on disclosure that will 
improve their well-being and quality of life. This in turn will likely have a considerable 
impact on levels of stigma and discrimination as well as on the HIV epidemic, as we 
progress towards the global vision of zero new HIV infections, zero discrimination, and 
zero AIDS-related deaths (UNAIDS, 2013). 
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Appendix A 
QUANTITATIVE SURVEY INSTRUMENT 
NO. QUESTIONS CODES 
Introduction 
I1 – I5 will be completed by the interviewer before the start of the interview 
I1 Interviewer Code  
Interviewer Code ___  ___ 
I2 Study site Identification Number (ID) 
 
 
Study Site ID ___  ___ 
I3 Date (MM/DD/YYYY) 
 
 
___  ___ / ___  ___ / ___ ___ ___ ___ 
I4 Study Participant Identification Number (ID) 
 
 
Participant ID ___ ___ ___ 
I5 Study Participant Gender  
Male     1 
Female     2 
 
Thank you for agreeing to participate in this study today. The purpose of this study is to help develop 
programs for young people living with HIV to help them stay healthy. 
 
This survey contains questions about sensitive topics such as drug and alcohol use, and sexual behavior. 
Everything you say will be kept private and strictly confidential. I will not share your individual answers 
with anyone from this youth center. I will combine what you tell me today with the answers from the 
same questions from all the other participants. No names will be used. 
 
All the information you can provide is important and will be helpful. But I do not want you to feel 
uncomfortable. Feel free to skip any questions that you do not feel comfortable answering. When you 
answer, please do so as honestly as possible. There are no right or wrong answers. We want to get a 
true picture of what you and other young people like you think or feel.  
 
I appreciate your time today as well as your important contribution to HIV prevention research. This 
survey will take approximately 45-60 minutes to complete. 
 
Do you have any questions before we get started?  
 
 
Demographics 
 
I would first like to ask you some things that will help me know more about you. 
DQ1 How old are you? [REGISTER AGE] 
 Age: ___  ___ years 
NOTE: CONTINUE WITH INTERVIEW ONLY IF RESPONDENT IS BETWEEN 18 AND 29 YEARS OLD 
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DQ2 What is the highest level of education you 
have completed? 
 
No formal education       1 
Some primary school     2 
Primary School       3 
Some secondary school     4 
Secondary School       5 
Post-Secondary      6 
Refuse to answer     -9 
DQ3 What is your religion? 
Catholic     1 
Protestant (Denomination _____________)    
2 
Christian     3 
Other (________________)     4 
No religion      5 
DQ4 Are you currently employed? 
Yes, full-time     1 
Yes, part-time     2 
No, not working     3 
DQ5 During the last 12 months, on average, how 
much money did you personally make per 
month? 
0 to 2,000 gdes     1 
2,001 to 5,000 gdes     2 
5,001 to 8,000 gdes     3  
8,001 to 11,000 gdes     4 
More than 11,001 gdes     5 
I don’t know     -8 
DQ6 During the last 12 months, from which of the 
following sources did you get any income? 
 
[READ EACH and SELECT ALL THAT APPLY] 
A job (type: _______________)     1 
Spouse or partner     2 
Other family     3 
Friends     4 
Sex work    5 
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Other     6 
Refuse to answer     -9 
DQ7 Describe your relationship status. 
 
[SELECT ONE] 
Single / Never married     1 
In a relationship (not living with partner)     2 
Co-habiting     3 
Married     4 
Separated     5 
Widowed     6 
Other     7 
Refuse to answer     -9 
DQ8 How many living children do you have? 
 
[IF ANSWER IS 0, CIRCLE CODE 0 AND SKIP TO 
QUESTION DQ10] 
Zero     0   
One     1 
Two     2 
Three     3 
More than three     4 
DQ9 How many of these children are HIV-
positive? 
 
[IF DQ8 = 0, DQ9 = -4 (VALID SKIP)] 
Number of HIV-positive children ___ 
I don’t know     -88 
DQ10 Do you identify as: 
 
[SELECT ONE] 
Straight / Heterosexual     1 
Gay / Homosexual    2 
Bisexual     3 
Other      4 
Refuse to answer     -9 
Health History.- This next sextion will ask you some basic information about your health. 
HQ1 We are doing this study with youth who are 
living with HIV. It is helpful for us to know 
how long you have been personally dealing 
with HIV. When did you first learn that you 
were HIV positive? 
 ___ / ________ 
mm / YYYY 
Refuse to answer(Year)     -9999 
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HQ2 What is the most likely way that you 
became infected with HIV? Perinatal (at birth)     1 
Sexual transmission (heterosexual or MSM)    2 
Blood transfusion or other medical procedure    
3 
I don’t know     -8 
Refuse to answer     -9 
HQ3 How many of your relatives have died of 
AIDS? None     1 
One     2 
Two or more     3 
HQ4 Are you currently taking HIV drug therapy 
to treat your HIV infection? 
 
[IF YES, GO TO QUESTION HQ5, IF NO SKIP 
HQ5 AND GO TO QUESTION HQ6] 
Yes     1 
No     2 
Refuse to answer   -9 
HQ5 How many months have you been or have 
you ever been on combination HIV drug 
therapy? 
 
[ESTIMATE IF YOU DO NOT KNOW THE 
EXACT  NUMBER OF MONTHS] 
[IF HQ4 = 2, HQ5 = 000] 
# of months ___ ___ ___ 
Don’t know     -888 
Refuse to answer     -999 
HQ6 How long has it been since you first started 
using services at this center?  Less than 6 months ago     1 
6 months to 2 years     2 
More than 2 years     3 
HQ7 What types of services have you received 
from this center, since your diagnosis? 
 
[READ ALL and CHECK ALL THAT APPLY] 
Medical care     1 
Counselling     2 
Nutritional support     3 
Support groups     4 
Positive prevention educational materials      5 
Condoms     6 
Other (________________)    7 
 71 
HQ8 Do you have an HIV case manager at this 
clinic or at any other location (someone 
who helps you coordinate and access the 
medical and social support services that 
you receive)? 
Yes     1 
No     2 
Refuse to answer     -9 
HQ9 During your visits to this or any other clinic, 
how much would you say that you and your 
counselor discuss HIV prevention issues 
such as safe sex and disclosure? 
A lot     1 
Somewhat     2 
A little     3 
Not at all     4 
I don’t know     -8  
HQ10 [FOR FEMALES ONLY] Have you used any of 
the following contraceptive methods in the 
last three months (other than condoms)? 
 
[IF I5 = 1, HQ10 = -4] 
Intrauterine device (IUD)     1 
Pill     2 
Injectable     3 
Other (___________________)     4 
None     5 
HQ11 [FOR FEMALES ONLY] Do you have any 
desire for a pregnancy in the future? 
 
[IF I5 = 1, HQ11 = -4] 
Yes     1 
No     2 
HQ12 In the last three months, have you been 
diagnosed and treated for any sexually 
transmitted infections (STI) such as 
gonorrhea, herpes, chlamydia, etc...? 
Yes (which one:_______________)     
1 
No     2 
HQ13 In the last three (3) months, how frequently 
have you used alcohol? By alcohol, we 
mean wine, beer, liquor 
No use     0 
Less than once a month     1 
  1 to 3 times a month     
2 
Once a week     3 
2 to 6 times a week    4 
Daily use     5 
Prefer not to answer     -9 
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HQ14 In the last three (3) months, how frequently 
have you used marijuana? No use     0 
Less than once a month     1 
1 to 3 times a month     2 
Once a week     3 
2 to 6 times a week    4 
Daily use     5 
Prefer not to answer     -9 
HQ15 In general, would you say your health is: 
 
[SELECT ONE] 
Poor     1 
Fair     2 
Good     3 
Very good     4 
Excellent     5 
Refuse to answer     -9 
 
NO. QUESTIONS CODES 
HIV Acceptance (Illness Cognition Questionnaire) Evers et al. 
Here is a list of statements by people with a long-term illness. Please indicate the extent to which 
you agree with them by choosing one of the answers following the statement. Do not spend too 
much time considering your answer. Your first impression is usually the best . 
 Not at all 
(1) 
Somewhat  
(2) 
To a large extent 
(3) 
Completely 
(4) 
IA1 I can handle the problems 
related to my HIV 
    
IA2 I have learned to live with my 
HIV 
    
IA3 I have learned to accept the 
limitations imposed by my HIV 
    
IA4 I can accept my HIV well     
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IA5 I think I can handle the 
problems related to my HIV, 
even if it gets worse 
    
IA6 I can cope effectively with my 
HIV 
    
 
NO. QUESTIONS CODES 
Depression (CES-D) (Radloff) 
Below is a list of the ways you might have felt or behaved. Please tell me how often you have felt this 
way during the past week. 
 less than 1 
day 
 (0) 
 1-2 days   
 
(1) 
3-4 days 
  
(2) 
5-7 days 
 
(3) 
DS1 I was bothered by things that usually don’t 
bother me 
    
DS2 I did not feel like eating; my appetite was 
poor 
    
DS3 I felt that I could not shake off the blues 
even with help from my family or friends 
    
DS4 I felt I was just as good as other people (R)     
DS5 I had trouble keeping my mind on what I 
was doing 
    
DS6 I felt depressed     
DS7 I felt that everything I did was an effort     
DS8 I felt hopeful about the future (R)     
DS9 I thought my life had been a failure     
DS10 I felt fearful     
DS11 My sleep was restless     
DS12 I was happy (R)     
DS13 I talked less than usual     
DS14 I felt lonely     
DS15 People were unfriendly     
DS16 I enjoyed my life (R)     
DS17 I had crying spells     
DS18 I felt sad     
DS19 I felt that people dislike me     
DS20 I could not get “going”     
  
 
7
4
 
NO. QUESTIONS CODES 
Beliefs and Attitudes 
Enhancing Prevention with Positives Evaluation Center (EPPEC) Project – CAPS/UCSF 
For the next section, select the response that best reflects the degree to which you agree or disagree with the following statements. 
 Strongly 
disagree 
 
(01) 
Disagree      
 
 
(02) 
Neither 
agree nor 
disagree 
(03) 
Agree  
 
 
(04) 
Strongly 
agree  
 
(05) 
I don’t 
know 
  
(-88) 
Refuse to 
answer 
 
 (-99) 
Patient-Provider Communication 
AT1 The staff at this clinic understand how complicated 
my life is living with HIV 
       
AT2 The staff at this clinic understand how sex fits into 
my life. 
       
AT3 I get support from staff at this clinic for coping with 
the challenge of being sexually active as a person 
living with HIV. 
       
AT4 Information, fliers and pamphlets about HIV and HIV 
transmission are easy to get at my clinic. 
       
AT5 HIV prevention media campaigns (TV ads, 
commercials, billboards, posters) address my needs 
as a person living with HIV. 
       
Perceived seriousness of transmission risk 
AT6 Because of HIV drug therapy, I am less concerned 
about infecting someone. 
       
AT7 The availability of HIV drug therapy makes me less 
worried about having unprotected sex. 
       
Beliefs about condom efficacy 
AT8 Condoms are easy to get at my clinic        
AT9 Using condoms correctly is an effective way to 
prevent HIV transmission. 
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NO. QUESTIONS CODES 
Moral norm 
AT10 Will using a condom every time you have vaginal or 
anal sex with a partner be considered a duty to you? 
Yes (1) No (2)      
Descriptive norm 
AT11 In your opinion, among the people you know who 
are living with HIV, how many use condoms every 
time they have vaginal or anal sex with a partner? 
None  ⃝         (0)                       Most ⃝    (2)                 I don’t know ⃝   (-8) 
Very few ⃝    (1)                         All  ⃝     (3) 
NO. QUESTIONS CODES 
Attitudes towards Condoms 
Now I am going to read to you some things that people think about sex and sexually transmitted infections (STI). For each one, tell me whether 
you agree or disagree by selecting the answer that best fits with what you believe. STEP (Thomas / Earp) 
 Agree a 
lot      
(1) 
Agree a 
little     
(2) 
Disagree 
a little    
 (3) 
Disagree 
a lot      
(4) 
I don’t 
know      
(-8) 
AC1 Just about any kind of sex feels better when you do not use a condom. Do you:      
AC2 Having to stop sex to put a condom takes the fun out of it. Do you:      
AC3 Using a condom during sex is like telling others that you might have an STI or 
HIV. Do you: 
     
AC4 Using a condom during sex feels uncomfortable. Do you:      
AC5 Using a condom during sex is embarrassing. Do you:      
NO. QUESTIONS CODES 
Intentions to avoid unsafe sex 
(Roffman’s Sex Check study) 
The next questions are about how you feel about having sex in the next 3 months with any partner. By sex, we mean vaginal or anal sex. 
 Not at all 
motivated 
(1) 
Somewhat 
motivated     
(2) 
Very 
motivated     
(3) 
Totally 
motivated      
(4) 
Refuse to 
answer       
(-9) 
US1 In the next 3 months, how motivated or unmotivated do you feel 
about having safer sex. Do you feel: 
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US2 In the next 3 months, how important or unimportant will it be to 
you to use a condom every single time you have sex? Would you 
say that for you it is: 
     
US3 In the next three months, how important or unimportant is it to 
you to tell any new partner that you have HIV? Would you say it is: 
     
 
NO. QUESTIONS CODES 
HIV Stigma Scale 
 
Next are some things that people living with HIV may have experienced in the past or may be experiencing right now. I realize that 
the next few questions may make you feel uncomfortable. For each question, please pick how much you agree or disagree with it 
by chosing the answer that best fits you. (Berger, 2001) 
 
The first set of questions asks about some of your experiences, feelings and opinions as to how people with HIV feel and how they are 
treated. 
 Strongly 
disagree 
(1) 
Disagree  
 
(2) 
Agree  
      
(3) 
Strongly 
agree  
(4) 
SS1 In many areas of my life, no one knows that I have HIV     
SS2 I feel guilty because I have HIV     
SS3 People’s attitudes about HIV make me feel worse about myself     
SS4 Telling someone I have HIV is risky     
SS5 People with HIV lose their jobs when their employers find out     
SS6 I work hard to keep my HIV a secret     
SS7 I feel I am not as good a person as others beacuse I have HIV     
SS8 I never feel ashamed of having HIV     
SS9 People with HIV are treated like outcasts     
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SS10 Most people believe that a person who has HIV is dirty     
SS11 It is easier to avoid friendships than worry about telling someone that I have HIV     
SS12 Having HIV makes me feel unclean     
SS13 Since learning I have HIV, I feel set apart and isolated from the rest of the world     
SS14 Most people think that a person with HIV is disgusting     
SS15 Having HIV makes me feel that I’m a bad person     
SS16 Most people with HIV are rejected when others find out     
SS17 I am very careful who I tell that I have HIV     
SS18 Some people who know I have HIV have grown more distant     
SS19 I worry about people discriminating against me     
SS20 Most people are uncomfortable around someone with HIV     
SS21 I never feel I need to hide the fact that I have HIV (R)     
SS22 I worry that people may judge me when they learn I have HIV     
SS23 Having HIV in my body is disgusting to me     
Many of the items in this next section assume that you hve told other people that you have HIV, or that others know. This may not be 
true for you. If the item refers to something that has not actually happened to you, please imagine yourself in that situation, then give 
your answer based on how you think you would feel or how you think others would react to you. 
SS24 I have been hurt by how people reacted to learning I have HIV.     
SS25 I worry that people who know I have HIV will tell others     
SS26 I regret having told some people that I have HIV     
SS27 As a rule, telling others that I have HIV has been a mistake     
SS28 Some people avoid touching me once they know I have HIV     
SS29 People I care about stopped calling after learning I have HIV     
SS30 People have told me that getting HIV is what I deserve for how I lived my life     
SS31 Some people close to me are afraid others will reject them if it becomes known that I 
have HIV 
    
SS32 People don’t want me around their children once they know I have HIV     
SS33 People have physically backed away from me when they learn I have HIV     
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NO. QUESTIONS CODES 
Discrimination 
 Yes 
(1) 
No 
(2) 
I don’t know 
  (-8) 
Refuse to answer 
(-9) 
 
DIS1 Thinking of your experiences since learning of your HIV 
diagnosis, have you ever felt you were discriminated against 
because of HIV? 
    
 
SS34 Some people act as though it’s my fault I have HIV     
SS35 I have stopped socializing with some people because of their reactions to my having 
HIV 
    
SS36 I have lost friends by telling them I have HIV     
SS37 I told people close to me to keep the fact that I have HIV a secret     
SS38 People who know I have HIV tend to ignore my good points     
SS39 People seem afraid of me once they learn I have HIV     
SS40 When people learn you have HIV, they look for flaws in your character     
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NO. QUESTIONS CODES 
Social Support 
 
The following questions ask about people in your life who provide you with help or support and the support that is available to you. Please 
answer all questions as best you can. All your answers will be kept confidential. (MOS Social Support Survey) 
MOS1 About how many close friends and relatives do you have (people you feel at ease 
with and can talk to about what is on your mind)? 
 
# of close friends and close relatives ___ ___ 
People sometimes look to others for companionship, assistance, or other types of support. How often is each of the following kinds of support 
available to you if you need it? 
 None of the 
time  
(1) 
A little of 
the time 
 (2) 
Some of 
the time 
(3) 
Most of 
the time    
(4) 
All of the 
time 
 (5) 
MOS2 Someone you can count on to listen to you when you need to talk      
MOS3 Someone to give you information to help you understand a situation      
MOS4 Someone to give you good advice about a crisis      
MOS5 Someone to confide in or talk to about yourself or your problems      
MOS6 Someone whose advice you really want      
MOS7 Someone to share your most private worries and fears with      
MOS8 Someone to turn to for suggestions about how to deal with a 
personal problem 
     
MOS9 Someone who understands your problems      
MOS10 Someone to help you if you were confined to bed      
MOS11 Someone to take you to the doctor if you needed it      
MOS12 Someone to prepare your meals if you were unable to do it yourself      
MOS13 Someone to help with daily chores if you were sick      
MOS14 Someone who shows you love and affection      
MOS15 Someone to love and make you feel wanted      
MOS16 Someone who hugs you      
MOS17 Someone to have a good time with      
MOS18 Someone to get together with for relaxation      
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NO. QUESTIONS CODES 
MOS19 Someone to do something enjoyable with      
MOS20 Someone to do things with to help you get your mind off things      
 
 
NO. QUESTIONS CODES 
Sexual Behavior Self-Efficacy (Safer Sex Self-Efficacy) 
 
The next section will ask you questions about your sexual activity. When we say “partner”, we mean a boyfriend, girlfriend, spouse or 
person who you have sexual activity with. This can include kissing, oral sex and intercourse. For the next questions, please tell me on a 
scale from 0 to 10 how confident you feel that you could do each of the following TODAY if you decided to do it, with zero (00) being 
“not at all confident” and 10 being “completely confident”. (Parsons, 1998) 
  
00 
 
01 
 
02 
 
03 
 
04 
  
05 
 
06 
 
07 
 
08 
 
09 
  
10 
SE1 How confident are you that you can talk with your partner(s) about 
sex? 
           
SE2 How confident are you that you can use a condom correctly?            
SE3 What if you DID want to have vaginal or anal sex but you didn’t have 
any condoms? How confident are you that you could switch to other 
sexual activities instead? 
           
SE4 How confident are you that you can convince your partner(s) to use 
condoms every single time you have sex? 
           
SE5 How confident are you that you could say NO to having sex with your 
partner? 
           
SE6 If a partner tells you that they would not use condoms, how 
confident are you that you would refuse to have sex with them? 
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NO. QUESTIONS CODES 
SE7 How confident are you that you can talk about using condoms with 
every future partner? 
           
Now please rate how confident you are that you CAN USE condoms in each of the following situations today, if you decided to do it. 
SE8 How confident are you that you can use condoms if you are feeling 
depressed? 
           
SE9 How confident are you that you can use condoms when you’ve been 
drinking or using drugs before sex? 
           
SE10 How confident are you that you can use condoms if condoms are 
NOT readily available and you (or your partner) have to go and get 
them? 
           
SE11 How confident are you that you can use condoms if you are feeling 
good? 
           
SE12 How confident are you that you can use condoms if you are in love 
with your partner? 
           
SE13 How confident are you that you can use condoms with a new 
partner? 
           
SE14 How confident are you that you can use condoms if you won’t see 
this partner again? 
           
SE15 How confident are you that you can use condoms with a partner who 
you have NOT used condoms with before? 
           
SE16 How confident are you that you can use a condom when your 
partner doesn’t want to use a condom? 
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NO. QUESTIONS CODES 
HIV SEROSTATUS DISCLOSURE 
 
Now I want to talk to you about whether or not you have ever talked to different people about your 
HIV status. Different people do different things when they learn they are HIV-positive. Some people 
tell their friends, families and sexual partners, others don’t tell anyone.  
 
Please remember that I will not tell anyone what you tell me today. 
SD1 How many people besides the medical 
staff at this clinic know about your HIV-
positive status?  
 
[IF ZERO, SKIP SECTION AND GO TO 
QUESTIONS SD6 THROUGH SD8] 
 
[IF # GREATER THAN OR EQUAL TO 1, 
CONTINUE WITH QUESTION SD2] 
# of people who know you are HIV(+) ___ ___ 
SD2 Of these, how many did you personally 
disclose your status to? 
 
 [IF # EQUAL TO 1, CONTINUE TO SD3] 
 
[IF # EQUAL TO 2, CONTINUE WITH SD3 
AND SD4] 
 
[IF NUMBER EQUAL TO 3 OR MORE, ASK 
QUESTIONS SD3 THRU SD5] 
# of people you personally told ___ ___ 
SD3 [IF NO DISCLOSURE] What are the 
reasons why you have not disclosed your 
status to anyone? 
 
[READ EACH AND CHECK ALL THAT APPLY] 
 
Fear of rejection    01 
Fear of negative consequences for yourself    02 
Fear of negative consequences for family     03 
Blame     04 
Loss of control of information     05  
Lack of confidence     06 
Shame     07 
Lack of communication skills     08 
Desire to become pregnant     09 
Possibility of subsequent questions regarding    10 
                      how the disease was transmitted   
Other (____________________)     11 
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NO. QUESTIONS CODES 
SD4 Who was the first person you disclosed 
to? 
 
[IF DISCLOSED TO MORE THAN ONE 
PERSON AT THE EXACT SAME TIME, 
CIRLCE ALL THAT APPLY] 
 
Mother     1 
Father     2 
Any brother     3 
Any sister     4 
Spouse     5 
Any friends     6 
Pastor/religious leader     7 
Any casual sexual partners     8 
Any main sexual partners     9 
 Other (_____________________________)     10 
SD4.1 What are the reasons you disclosed your 
status to this person?  
 
[READ EACH AND CHECK ALL THAT APPLY] 
Emotional support     01 
Financial support     02 
Medical or home care     03 
Because he/she should know     04 
Encourage partner to get tested   05 
Desire to protect others     06 
To encourage him/her to get tested     07 
To encourage condom use in future     08 
Need to educate     09 
Because he/she is HIV-positive     10 
Other:( ___________)     11     
SD4.2 When did you disclose your status to this 
person? Within 24 hours of diagnosis     1 
In the first week after diagnosis     2 
In the first month after diagnosis     3 
1 to 6 months after     4 
6 to 12 months after     5 
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NO. QUESTIONS CODES 
Over a year after     6 
SD4.3 After you told this person you were HIV+, 
would you say that their response was 
positive, negative or neutral? 
 
 
Positive (supportive)     1 
Negative (unsupportive)    2 
Neutral     3 
SD4.4 After you disclosed to this person, did you 
feel confident for future disclosures to 
other people?  
Not at all confident     1 
Somewhat confident     2 
Completely confident     3 
I don’t know     -8      
SD5 Who was the second person you 
disclosed to? 
 
 
[IF DISCLOSED TO MORE THAN ONE 
PERSON AT THE EXACT SAME TIME, 
CIRLCE ALL THAT APPLY] 
Mother     1 
Father     2 
Any brother     3 
Any sister     4 
Spouse     5 
Any friends     6 
Pastor/religious leader     7 
Any casual sexual partners     8 
Any main sexual partners     9 
  Other (_____________________________)     10 
SD5.1 What are the reasons you disclosed your 
status to this person?  
 
[READ EACH AND CHECK ALL THAT APPLY] 
Emotional support     01 
Financial support     02 
Medical or home care     03 
Because he/she should know     04 
Encourage partner to get tested   05 
Desire to protect others     06 
To encourage him/her to get tested    07 
To encourage condom use in future     08 
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NO. QUESTIONS CODES 
Need to educate     09 
Because he/she is HIV-positive     10 
Other:( ___________)     11     
SD5.2 When did you disclose your status to this 
person? Within 24 hours of diagnosis     1 
In the first week after diagnosis     2 
In the first month after diagnosis     3 
1 to 6 months after     4 
6 to 12 months after     5 
Over a year after     6 
SD5.3 After you told this person you were HIV+, 
would you say that their response was 
positive, negative or neutral? 
 
 
 
Positive (supportive)     1 
Negative (unsupportive)    2 
Neutral     3 
SD5.4 After you disclosed to this person, did you 
feel confident for future disclosures to 
other people?  
Not at all confident     1 
Somewhat confident     2 
Completely confident     3 
I don’t know     -8      
SD6 Who was the third person you disclosed 
to? 
 
[IF DISCLOSED TO MORE THAN ONE 
PERSON AT THE EXACT SAME TIME, 
CIRLCE ALL THAT APPLY] 
Mother     1 
Father     2 
Any brother     3 
Any sister     4 
Spouse     5 
Any friends     6 
Pastor/religious leader     7 
Any casual sexual partners     8 
Any main sexual partners     9 
  Other (_____________________________)    10 
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NO. QUESTIONS CODES 
SD6.1 What are the reasons you disclosed your 
status to this person?  
 
[READ EACH AND CHECK ALL THAT APPLY] 
Emotional support     01 
Financial support     02 
Medical or home care     03 
Because he/she should know     04 
Encourage partner to get tested   05 
Desire to protect others     06 
To encourage him/her to get tested     07 
To encourage condom use in future     08 
Need to educate     09 
Because he/she is HIV-positive     10 
Other:( ___________)     11     
SD6.2 When did you disclose your status to this 
person? Within 24 hours of diagnosis     1 
In the first week after diagnosis     2 
In the first month after diagnosis     3 
1 to 6 months after     4 
6 to 12 months after     5 
Over a year after     6 
SD6.3 After you told this person you were HIV+, 
would you say that their response was 
positive, negative or neutral? 
 
 
 
Positive (supportive)     1 
Negative (unsupportive)    2 
Neutral     3 
SD6.4 After you disclosed to this person, did you 
feel confident for future disclosures to 
other people?  
Not at all confident     1 
Somewhat confident     2 
Completely confident     3 
I don’t know     -8 
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NO. QUESTIONS CODES 
QUESTIONS SD7 THROUGH SD 8.1 FOR ALL PARTICIPANTS 
SD7 How many close friends would you say 
you have? # of close friends ___ ___ 
SD7.1 How many of your close friends have you 
disclosed your status to? # of close friends disclosed to ___ ___ 
SD8 How many immediate family members 
(mother, father, brother, sister, children) 
would you say you have? 
# of family members ___ ___ 
SD8.1 How many of your immediate family 
members have you disclosed your status 
to? 
# of family members disclosed to ___ ___ 
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NO. QUESTIONS CODES 
Sexual Behavior 
 
The next questions are about your sexual behavior. Please remember that all your answers are 
strictly confidential. Your answers are protected and will not be share with anyone else outside of 
the research team. 
 
SB1 How many lifetime sexual partners have 
you had overall? By sexual partners, we 
mean partners with whom you have had 
vaginal or anal sex. 
 
 
# of lifetime partners ___ ___ 
SB2 Age at first sex (vaginal or anal sexual 
activity) 
 
 
Age at first sex ___ ___ 
SB3 Since your HIV diagnosis, how many 
sexual partners have you had? 
 
 
# of sexual partners since HIV diagnosis ___ ___ 
 
The following questions ask you about the sexual relationships you might have had in the last 3 months 
with partners who are HIV-positive, HIV-negative, as well as partners whose HIV status you are not sure 
of. Again these questions are about the last 3 months. 
 
[USE CALENDAR] 
 
SB4 How many sexual partners have you had 
in the last 3 months? 
 
 
SB 4.1: # of male sexual partners    ___ ___                
 
SB 4.2: # of female sexual partners ___ ___  
SEXUAL PARTNERS   (UP TO 5)                                          P1                 P2               P3              P4             P5 
M / F                                                                                     ____           _____         _____          _____       _____ 
SB5 How would you describe your relationship 
with each partner? Do you consider them 
as your main or casual partners? 
 
A main partner (1)  is someone you have 
lived with or seen a lot, and to whom you 
have felt a special emotional 
commitment. 
 
 A casual partner (2) is someone with 
whom you have no emotional connection. 
 
    
    
   1                  1                  1                 1              1 
 
   2                  2                  2                 2              2 
 
SB6 What is your sexual partner’s HIV status? 
 
Positive   1 
Negative 2 
Unknown 3 
   1                  1                    1                1             1 
 
   2                  2                    2                2             2 
 
   3                  3                    3                3             3 
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SEXUAL PARTNERS   (UP TO 5)                                          P1                 P2               P3              P4             P5 
M / F                                                                                     ____           _____         _____          _____       _____ 
SB7 Have you personally told this partner that 
you are HIV-positive? 
 
Yes   1 
No    2 
 
[IF NO: GO TO SB8, SKIP SB9 AND SB10] 
[IF YES: SKIP SB8, GO TO SB9 AND SB10] 
    
  1                   1                  1                 1                 1 
 
  2                    2                 2                 2                 2 
 
SB8 Does this person know that you are HIV-
positive? 
 
Yes          1 
No           2 
Maybe    3 
 
[IF SB7 = 1, SB8 = -4 (VALID SKIP)] 
  1                   1                  1                 1                 1 
 
  2                   2                  2                 2                 2 
 
  3                   3                  3                 3                 3 
SB9 What is the main reason you disclosed 
your HIV status to this partner? 
 
 
P1: _________________________________ 
P2: _________________________________ 
P3: _________________________________ 
P4: _________________________________ 
P5: _________________________________ 
SB10 After yout told this partner that you were 
HIV-positive, how would you say that their 
reaction was? 
 
Supportive      1 
Unsupportive 2 
Neutral            3 
 
[IF SB7 = 2, SB10 = -4 (VALID SKIP)] 
 
  1                   1                  1                 1                 1 
 
  2                   2                  2                 2                 2 
 
  3                   3                  3                 3                 3 
  
QUESTIONS SB11 AND SB12 FOR ALL PARTICIPANTS 
SB11 How many times did you have vaginal or 
anal sex with your partner?  
 
 
_____         ______         ______       _____      _____ 
SB12 How many of these times was a condom 
used? 
 
 
_____         ______        ______        _____      _____ 
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NO. QUESTIONS CODES 
Socially Desirable Response Set (SDRD-5) / (RAND) 
 
Listed below are a few statements about your relationships with others. How much is each statement True or False for you? 
 Definitely 
True      
(1) 
Mostly  
True 
(2) 
Don’t  
know  
(3) 
Mostly 
False  
(4) 
Definitely 
False  
(5) 
SDR1 I am always courteous even to people who are 
disagreeable 
     
SDR2 There have been occasions when I took advantage of 
someone 
     
SDR3 I sometimes try to get even rather than forgive and forget      
SDR4 I sometimes feel resentful when I don’t get my way      
SDR5  No matter who I’m talking to, I’m always a good listener      
 
NO. QUESTIONS CODES 
Subjective norms 
 
The next questions will ask you about what three different groups of people think about whether or not people living with HIV should use 
condoms and tell their HIV status to partners. I will ask you about three different groups of people: your friends, your close family members, 
and your sex partners. 
 
 
 
Agree a 
lot 
 (1) 
Agree a 
little 
 (2) 
Disagree 
a little  
(3) 
Disagree 
a lot  
(4) 
I don’t 
know 
(5) 
SN1 Most of my friends think that people living with HIV should always wear a 
condom when having vaginal or anal sex. 
     
SN2 Most of my friends think that people living with HIV should always tell 
their sex partners their HIV status before having vaginal or anal sex with 
them. 
     
SN3 Most of my close family members think that people living with HIV 
should always wear a condom when having vaginal or anal sex. 
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NO. QUESTIONS CODES 
  Agree a 
lot 
 (1) 
Agree a 
little 
 (2) 
Disagree 
a little  
(3) 
Disagree 
a lot  
(4) 
I don’t 
know 
(5) 
SN4 Most of my close family members think that people living with HIV 
should always tell their sex partner their HIV status before having vaginal 
or anal sex with them. 
     
SN5 Most of my sex partners think that people living with HIV should always 
wear a condom when having vaginal or anal sex. 
     
SN6 Most of my sex partners think that people with HIV should always tell 
their sex partner their HIV status before gaving vaginal or anal sex with 
them. 
     
  Not at all 
important     
(1) 
Somewhat 
important 
(2) 
Very 
important 
(3) 
Extremely 
important 
(4) 
I don’t 
know  
(5) 
SN7 In general, how important or unimportant is it to you what your friends 
think you should do? Is it: 
     
SN8 In general, how important or unimportant is it to you what your family 
members think you should do? Is it: 
     
SN9 In general, how important or unimportant is it to you what your sex 
partners think you should do? Is it: 
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These are all the questions I have for you. Is there anything you would like to add about your experiences 
with living with HIV? 
 
 
 
Do you have any questions for me? 
 
 
 
 
 
 
 
 
Follow-up In-depth interview:  
We will be contacting a small number of survey participants to see if they would consider talking to us a 
little more about their experiences with disclosure in one-on-one interviews. Would you be interested in 
participating? 
 Yes (  )   No (  ) 
 
If yes: Please complete separate locator form. Provide a phone number or email (that you are the only one 
with access to) so that we can contact you. No names will be used on this separate form; only your unique 
ID number will link your locator form to your survey. 
 
 
All your information will be kept confidential and private.  
 
 
THANK YOU very much for taking the time to be part of this study. The information you provided will help 
to improve services for young people living with HIV in Haiti. 
 
 
LOCATOR FORM 
Interviewer Code: ___ ___                  Study Site ID: ___ ____               Study Participant ID: ___ ___ ___ 
 
Provide a phone number or email (that you are the only one with access to) so that we can contact 
you, in case you are chosen to participate in the in-depth interviews. 
 
Email: _________________________________________________ 
 
Phone number: _________________________________________ 
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Appendix B 
Qualitative Interview Guide 
 
 
A) Introduction / Personal information 
I would like to learn a little about yourself, before we begin this interview. 
1. When were you born? 
2. How much school did you complete? 
3. What types of economic activities are you involved in? Has this changed since being 
diagnosed HIV positive? Do you get enough money to support yourself? 
4. Where do you live now? 
5. Who do you live with at home? 
6. Are you currently married? Probe: Relationship status 
7. Do you have any children? How many? Ages? 
 
  
B) Experience with HIV 
1. Is anyone else in your family HIV-positive? (Probe: who else? Spouse? Children?) 
2. Has anyone in your family died of AIDS? 
3. Please tell me about the events that led to you being diagnosed with HIV? (Probe: 
Motivation for being tested, illness, where tested) 
4. When did you learn that you were HIV-positive? (Probe: How did you feel about 
that?) 
5. How did your life change after learning of your HIV-positive status? (Probe: 
reactions, intentions, decisions about future) 
6. How do you think you became infected? 
 
C) Disclosure 
I would like to ask you some questions about who in your life knows that you are HIV-
positive, other than people at the clinic. 
1. Tell me about the first time you disclosed your HIV status. Who was the first person 
you told? Why did you decide to tell this person first? (Probe: When? What was 
their reaction? Did their reaction make you more or less confident to ever disclose 
your status to someone else? Please explain.) 
2. Who was the second person you told about your HIV status? (Probe: When? Why? 
What was their reaction? Did their reaction make you more or less confident to ever 
disclose your status to someone else? Please explain) 
3. Same question up to 5 people 
4. Who else knows about your HIV infection besides these people? (Probe: Did you 
personally tell them?) 
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5. How did you decide who you wanted to disclose your status to? 
6. For each person mentioned:  
6a. How has your relationship with this person changed since telling them about 
your HIV status? 
6b. Has this person helped you in dealing with your HIV status? (Probe: How? Can 
you give me some examples?) 
6c. Did you get any unsupportive reactions after disclosing your status? 
7. How do you feel about disclosing your status to your sexual partners? 
8. What made you decide to share your HIV test result with your partner(s)? How did it 
go the first time you told a sexual partner about your HIV-status? (Probe: What did 
you say to them? Was it a stressful experience? How long had your relationship 
been going on at the time? How did you decide the right time to tell him/her? What 
was their reaction?  Did their reaction make you more or less confident to ever 
disclose your status to another sexual partner? Please explain). Same questions for 
other sexual partners. 
9. Did you consider not having sexual intercourse after learning of your HIV diagnosis? 
(Probe: Why or why not?) 
10. What are your feelings about knowing your sexual partner’s HIV status? (Probe: 
Would you want them to tell you? How would that change your decision to have 
protected or unprotected sexual intercourse? Please explain.) 
 
D) Non-Disclosure 
1. Why haven’t you disclosed your status to anyone in your family or to just some of 
them? (Probe: What are your fears? Do you think that they know of your status 
even if you haven’t told them?) 
2. Why haven’t you disclosed your status to your friends or to just some of them? 
(Probe: What are your fears? Do you think that they know of your status even if you 
haven’t told them?) 
3. Why haven’t you told any or some of your sexual partners? (Probe: What are your 
fears? Does it matter how long you have been in a relationship with them? Do you 
think that they know of your status even if you haven’t told them? How do you feel 
about condom use with your partners whom you haven’t disclosed to? Can you 
please explain?) 
4. What are your reasons for not telling these people about your HIV status? (Probe: 
Do you think you will eventually tell them? Why or why not?) 
5. Has anyone learned of your HIV status without you wanting them to? (Probe: Who? 
How do you fell about that? How did they find out?) 
 
Thank you for your time in answering these questions. Do you have anything else you would like 
to tell me? 
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